Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1050.Time spend outdoors in summer,49121,0.059001717982899,0.0274975693325702,0.00510648209106138,0.112896953874737,0.0319058896943606
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1060.Time spent outdoors in winter,45337,0.00391075980228981,0.0313987509386338,-0.0576307920374325,0.0654523116420121,0.900879835896247
CD300E,CMRF35-like molecule 2,Physical activities,X1070.Time spent watching television (TV),50298,0.238152780120922,0.0273543781101376,0.184538199025052,0.291767361216792,3.32204830718706e-18
CD300E,CMRF35-like molecule 2,Physical activities,X1080.Time spent using computer,45287,-0.0341428801133384,0.0290769006726788,-0.0911336054317888,0.022847845205112,0.240317188811135
CD300E,CMRF35-like molecule 2,Physical activities,X1090.Time spent driving,44168,-0.134280108235479,0.0305220159810952,-0.194103259558426,-0.0744569569125325,1.09077523729114e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1160.Sleep duration,52111,0.0226210568307545,0.0255584588025327,-0.0274735224222096,0.0727156360837185,0.376125742711058
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34561,0.00340049256765697,0.0132389053475998,-0.0225477619136387,0.0293487470489526,0.79729485898115
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34561,-0.000353101546871124,0.0130427430488465,-0.0259168779226102,0.025210674828868,0.978402298050561
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34561,0.0144795684506371,0.015295823289527,-0.0155002451968358,0.0444593820981101,0.343845951951803
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34561,0.0270318677896959,0.0158825971584911,-0.00409802264094661,0.0581617582203385,0.0887881039247439
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34561,0.0242280746385762,0.0163449904883541,-0.0078081067185979,0.0562642559957502,0.138291639645719
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34561,-0.00678964767047092,0.0314372575557059,-0.0684066724796544,0.0548273771387126,0.829011699126994
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34561,0.034207982456227,0.032555749379944,-0.0296012863284632,0.0980172512409171,0.29339674687794
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34561,0.0228478158542489,0.0229067419398745,-0.0220493983479051,0.067745030056403,0.318579569805654
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34561,0.0250029760624207,0.0168982630785871,-0.00811761957161008,0.0581235716964515,0.139004627988609
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34561,0.0167227364619694,0.0118548104868522,-0.00651269209226087,0.0399581650161996,0.158383178743723
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34561,0.0456643452493278,0.0168253753157066,0.0126866096305428,0.0786420808681128,0.0066579343928956
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34561,0.00601142322598185,0.00964465214249687,-0.012892094973312,0.0249149414252757,0.533106707377855
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34561,-0.000981761833074721,0.0123774444470525,-0.0252415529492977,0.0232780292831482,0.936780678175805
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34561,0.00969542376498872,0.0187215115427858,-0.0269987388588715,0.0463895863888489,0.604555409938395
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34561,0.0307915146704826,0.0177676052721252,-0.00403299166288273,0.065616021003848,0.0831219286029625
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34561,0.0327859039451798,0.0219668187887895,-0.0102690608808475,0.0758408687712072,0.135592506514543
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34561,0.00937366782740287,0.0206770433777983,-0.0311533371930817,0.0499006728478874,0.650315320265818
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34561,0.01501811528541,0.0137641854510821,-0.0119596881987108,0.0419959187695309,0.275253048294643
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34561,0.0176899162107654,0.0131133308778489,-0.00801221230981849,0.0433920447313493,0.17736470507458
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34561,0.0220809639664246,0.0161682443812166,-0.00960879502075987,0.0537707229536091,0.172061991403585
CD300E,CMRF35-like molecule 2,Health and medical history,X120040.Fatigue severity over the past week,34569,0.206639185433863,0.043893575691443,0.120607777078635,0.292670593789091,2.53631384283322e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34571,0.164487333006698,0.0435387744163791,0.0791513351505945,0.249823330862801,0.00015898093387428
CD300E,CMRF35-like molecule 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34569,0.0556276132142515,0.047958748272714,-0.0383715334002679,0.149626759828771,0.246113169718947
CD300E,CMRF35-like molecule 2,Health and medical history,X120098.Mobility problems today,34574,0.292572848908292,0.0535328881092517,0.187648388214159,0.397497309602425,4.7250137344786e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X120099.Self-care problems today,34574,0.299224321754995,0.0823404624837575,0.137837015286831,0.46061162822316,0.000280378959664081
CD300E,CMRF35-like molecule 2,Health and medical history,X120100.Problems doing usual activities,34574,0.223096805990682,0.0504856613564592,0.124144909732022,0.322048702249343,1.00127437293675e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X120101.Pain or discomfort today,34574,0.143076783089797,0.0441869488742572,0.0564703632962532,0.229683202883341,0.00120742681451915
CD300E,CMRF35-like molecule 2,Health and medical history,X120102.Anxiety or depression today,34574,0.144892438589961,0.0517632936352346,0.0434363830649017,0.246348494115021,0.00513313767357644
CD300E,CMRF35-like molecule 2,Health and medical history,X120103.Scale to indicate how health is today,34538,-0.0202834495170179,0.00416535334188244,-0.0284475420671074,-0.0121193569669283,1.13449178898859e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34558,0.191959767532075,0.0519269628362739,0.0901829203729785,0.293736614691172,0.000219489092806296
CD300E,CMRF35-like molecule 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34543,0.087579254135184,0.0532317263652223,-0.0167549295406517,0.19191343781102,0.0999486348855256
CD300E,CMRF35-like molecule 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34563,0.171082161273034,0.0432952871428593,0.0862233984730302,0.255940924073039,7.8155550368707e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34564,0.193888516069201,0.0444337655473791,0.106798335596338,0.280978696542064,1.29174263502472e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34560,0.233899643629465,0.0540758508623834,0.127910975939193,0.339888311319736,1.53636601624907e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34533,0.0892969392860629,0.0552812517320989,-0.0190543141088509,0.197648192680977,0.106270869422186
CD300E,CMRF35-like molecule 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34565,0.124598222167905,0.0555220973627899,0.0157749113368369,0.233421532998973,0.0248450669778879
CD300E,CMRF35-like molecule 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34549,0.303140294531217,0.0818909039894271,0.14263412271194,0.463646466350494,0.000215187392809352
CD300E,CMRF35-like molecule 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34498,0.168280274515188,0.107025349108599,-0.0414894097376669,0.378049958768042,0.115901385514936
CD300E,CMRF35-like molecule 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31518,0.183435371284993,0.0572846313726977,0.0711574937945056,0.295713248775481,0.00136952333226554
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49022,0.132394718585306,0.0591563382259694,0.0164482956624063,0.248341141508206,0.0252266447279071
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47725,0.051928242761823,0.036579432172881,-0.0197674442970237,0.12362392982067,0.155736583768252
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1289.Cooked vegetable intake,51086,-0.181183255546744,0.0263004228238481,-0.232732084281486,-0.129634426812002,5.74137049936719e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50537,-0.140802439404732,0.028210708378769,-0.19609542782712,-0.0855094509823449,6.04144214817924e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1309.Fresh fruit intake,51060,-0.0968113698102778,0.0280235578791648,-0.151737543253441,-0.0418851963671148,0.000551862967453739
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1319.Dried fruit intake,49510,-0.145324159224255,0.0296425325257166,-0.203423522974659,-0.0872247954738503,9.51755891967409e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X134.Number of self-reported cancers,52339,0.265231147133343,0.0567780948637108,0.15394608120047,0.376516213066216,3.00572217980213e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52339,0.283301186171234,0.0257623030075182,0.232807072276498,0.333795300065969,4.51288364913779e-28
CD300E,CMRF35-like molecule 2,Health and medical history,"X136.Number of operations, self-reported",52339,0.14829174947834,0.0255993565120898,0.0981170107146442,0.198466488242036,6.99536316422315e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X137.Number of treatments or medications taken,52339,0.282576906054449,0.0257531434359488,0.23210074491999,0.333053067188909,5.89404304638869e-28
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1438.Bread intake,51459,0.0101588983661209,0.00273210959567088,0.00480396355860601,0.0155138331736358,0.00020093693329906
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1458.Cereal intake,50700,0.147968676181247,0.0264143971466013,0.0961964577739081,0.199740894588585,2.14190350366679e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1488.Tea intake,51238,0.0132412492027429,0.00257998580271559,0.00818447702942035,0.0182980213760655,2.88184371844749e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1498.Coffee intake,49992,-0.272245612311599,0.0266401749742999,-0.324460355261227,-0.220030869361971,1.80575318070147e-24
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1528.Water intake,50308,-0.0833257525013,0.0272636830196319,-0.136762571219778,-0.0298889337828215,0.00224316922518835
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1568.Average weekly red wine intake,43178,-0.317150491582567,0.0315502632707365,-0.378989007593211,-0.255311975571924,1.02719387466616e-23
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43172,-0.142910149542055,0.0323604326620488,-0.206336597559671,-0.0794837015244396,1.00996613063691e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,43223,0.00970975105204396,0.0353465882343489,-0.05956956188728,0.0789890639913679,0.783548721580512
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1598.Average weekly spirits intake,43144,0.0262507991702231,0.0351288073537756,-0.042601663243177,0.0951032615836233,0.45490807209703
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1608.Average weekly fortified wine intake,43213,-0.0290109682440933,0.0643707183237731,-0.155177576158689,0.097155639670502,0.652221072303178
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1737.Childhood sunburn occasions,45771,-0.0734885308776605,0.0309558895756522,-0.134162074445939,-0.0128149873093823,0.0176062740731787
CD300E,CMRF35-like molecule 2,Health and medical history,X1807.Father's age at death,40827,-0.0100116988108141,0.00367206598375644,-0.0172089481389767,-0.0028144494826515,0.00640856789742511
CD300E,CMRF35-like molecule 2,Health and medical history,X1845.Mother's age,40097,-0.0158504445330184,0.00548699034046414,-0.0266049456003281,-0.00509594346570865,0.00387309977783315
CD300E,CMRF35-like molecule 2,Health and medical history,X1873.Number of full brothers,51837,0.0266093537833672,0.0256115126587349,-0.0235892110277532,0.0768079185944877,0.298832017665203
CD300E,CMRF35-like molecule 2,Health and medical history,X1883.Number of full sisters,51838,0.0428194012037361,0.0255012095005348,-0.00716296941731217,0.0928017718247844,0.0931412752898971
CD300E,CMRF35-like molecule 2,Physical measures,X20015.Sitting height,52104,0.00107491347579169,0.00345494818758718,-0.00569678497187918,0.00784661192346256,0.75570949410448
CD300E,CMRF35-like molecule 2,Cognitive function,X20016.Fluid intelligence score,32840,-0.118506876355499,0.044010376117855,-0.204767213546495,-0.0322465391645029,0.00710070511087303
CD300E,CMRF35-like molecule 2,Cognitive function,X20018.Prospective memory result,33173,0.0696435166974564,0.0618339497750591,-0.0515510248616595,0.190838058256572,0.260067999253208
CD300E,CMRF35-like molecule 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32749,0.00890132542890319,0.00473479545402579,-0.000378873660987364,0.0181815245187937,0.0601433457011366
CD300E,CMRF35-like molecule 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32742,0.0183533395870616,0.00469911179429355,0.00914308047024626,0.027563598703877,9.4647593780951e-05
CD300E,CMRF35-like molecule 2,Cognitive function,X20023.Mean time to correctly identify matches,52025,0.0148088033617875,0.00274631471657624,0.00942602651729809,0.0201915802062769,7.01420453291424e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49058,0.00356939988038153,0.00594197386013679,-0.00807686888548657,0.0152156686462496,0.548038923216426
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48631,-0.00994569705216176,0.0135107902670883,-0.0364268459756548,0.0165354518713313,0.461658602230121
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48593,0.00601401107779661,0.0181356262276542,-0.0295318163284056,0.0415598384839988,0.740184242680403
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48627,-0.0119918067251216,0.013847941198303,-0.0391337714737955,0.0151501580235523,0.386518760830702
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48628,0.00447809290513682,0.0100883120835467,-0.0152949987786148,0.0242511845888884,0.657126562033193
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48795,-0.00504610304644434,0.0077938614841017,-0.0203220715552837,0.010229865462395,0.517349409181108
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48731,0.00417678005481069,0.0101267377392393,-0.0156716259140983,0.0240251860237197,0.680012664664936
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48632,0.0039970571028751,0.0122136706473761,-0.0199417373659821,0.0279358515717323,0.743473312399457
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48758,0.022771765708951,0.00967613311586792,0.00380654480184987,0.0417369866160521,0.018610579750389
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48916,-0.000410660416658298,0.00613100571680243,-0.0124274316215911,0.0116061107882745,0.946597425426511
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48762,0.014510280486096,0.00836631102221061,-0.00188768911743677,0.0309082500896288,0.0828647943854209
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50131,0.0187676422665939,0.00713425372585527,0.00478450496391762,0.0327507795692703,0.00852743659495768
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49999,-0.0118719258704925,0.0115251191548189,-0.0344611594139376,0.0107173076729527,0.302976643483311
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49943,0.0087151351330074,0.0241449694627818,-0.038609005014045,0.0560392752800598,0.71813948798699
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49990,0.0159371193248224,0.0103721427038682,-0.00439228037475935,0.0362665190244041,0.124420296305982
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50077,0.0230046537803851,0.00843629005529716,0.00646952527200263,0.0395397822887675,0.00639810202965495
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49997,0.000129010084611374,0.0137814158406264,-0.0268825649630164,0.0271405851322391,0.992531052839111
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49972,-0.0115380507473984,0.0130799737365976,-0.0371747992711298,0.0140986977763329,0.377722339788421
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50007,0.00165773269401927,0.0098896305099483,-0.0177259431054794,0.0210414084935179,0.866880920871602
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50011,0.0598345530614056,0.0116244852534993,0.0370505619645471,0.0826185441582642,2.66192946035307e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50229,0.00756796744816281,0.00560296680195408,-0.0034138474836672,0.0185497823799928,0.17680084428729
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50064,0.0402759416298789,0.00867851769651476,0.02326604694471,0.0572858363150478,3.48610671734298e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,47250,0.0157580087767165,0.0114383352920071,-0.00666112839561752,0.0381771459490504,0.168324930152534
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,47136,0.0869584878112396,0.0632657113441975,-0.0370423064233874,0.210959282045867,0.169300882820056
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,47134,-0.0860445832528326,0.0555861867358094,-0.194993509255019,0.0229043427493538,0.121648167875093
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,47221,0.00921873882048953,0.0104547005336701,-0.0112724742255039,0.029709951866483,0.377905224544867
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,47141,0.0146532633742562,0.0350758164971753,-0.0540953369602074,0.0834018637087197,0.676126654552368
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,47155,0.032427452780102,0.0197270395879664,-0.00623754481231219,0.0710924503725162,0.100229496117098
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,47143,0.0398930579895911,0.0266654370114198,-0.0123711985527917,0.092157314531974,0.134651923389863
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,47151,0.00913063676673795,0.0234891015048515,-0.0369080021827709,0.0551692757162468,0.697488312179988
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,47156,0.0305737441522191,0.0158175002333446,-0.000428556305136229,0.0615760446095745,0.0532598594556505
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,47160,0.0491951751234418,0.0208378936038572,0.00835290365988158,0.0900374465870019,0.018241210799197
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47345,0.00418291034735014,0.00734423473337777,-0.0102117897300703,0.0185776104247706,0.568988262165005
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,47235,0.0284302664284897,0.0107572484609701,0.00734605944498834,0.0495144734119911,0.00822555885002247
CD300E,CMRF35-like molecule 2,Mental health,X20127.Neuroticism score,46709,0.108197694313896,0.0267156350866351,0.0558350495440914,0.160560339083701,5.13918508681993e-05
CD300E,CMRF35-like molecule 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32840,-4.07539108820996e-05,0.0447505227573308,-0.0877517785152504,0.0876702706934862,0.999273393841466
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20161.Pack years of smoking,31713,0.0285726773035727,0.00566377374365546,0.017471680766008,0.0396736738411374,4.64142379711536e-07
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31713,0.0267512258802319,0.00529537412785741,0.0163722925896314,0.0371301591708324,4.47505679578188e-07
CD300E,CMRF35-like molecule 2,Cognitive function,X20191.Fluid intelligence score,31439,-0.00748463744137804,0.0482195014137644,-0.101994860212356,0.0870255853296003,0.876651916544154
CD300E,CMRF35-like molecule 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31439,-0.0255343889273758,0.0491811658490584,-0.12192947399153,0.0708606961367786,0.603643160569808
CD300E,CMRF35-like molecule 2,Cognitive function,X20240.Maximum digits remembered correctly,30791,-0.094355697641278,0.0508160290958914,-0.193955114669225,0.00524371938666912,0.0633806738415651
CD300E,CMRF35-like molecule 2,Physical measures,X20255.Spirometry QC measure,45159,-0.000342766041868237,0.034770165504815,-0.0684922904313056,0.0678067583475691,0.992134633548921
CD300E,CMRF35-like molecule 2,Eye measures,X20261.avMSE,29980,0.0103517151095417,0.00585156212225273,-0.00111734665007367,0.021820776869157,0.0769350672857533
CD300E,CMRF35-like molecule 2,Eye measures,X20262.Myopia diagnosis,29980,-0.0336555960802439,0.0648570167706961,-0.160775348950808,0.0934641567903205,0.60383537215871
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20280.Glucose-lactate,39952,-0.00818765977113046,0.00354068121517581,-0.015127394952875,-0.00124792458938587,0.0207652734835054
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39987,-0.014021058764495,0.00349921543537802,-0.0208795210178359,-0.00716259651115408,6.17932489171161e-05
CD300E,CMRF35-like molecule 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32721,-0.0137179653683685,0.0170381677213783,-0.04711277410227,0.0196768433655331,0.42076540848087
CD300E,CMRF35-like molecule 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32718,0.0160003389237441,0.0343335089699996,-0.051293338657455,0.0832940165049432,0.641207701248699
CD300E,CMRF35-like molecule 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32716,-0.0176301741960797,0.0378529879646068,-0.0918220306067091,0.0565616822145496,0.64140316894842
CD300E,CMRF35-like molecule 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32716,-0.0134276852310572,0.0164521981810881,-0.0456739936659898,0.0188186232038755,0.414428526406113
CD300E,CMRF35-like molecule 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32716,-0.0535401153684094,0.0265753420874149,-0.105627785859743,-0.00145244487707622,0.0439710989826818
CD300E,CMRF35-like molecule 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32723,-0.00175433300644162,0.0339602925798342,-0.0683165064629166,0.0648078404500333,0.958802081288631
CD300E,CMRF35-like molecule 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32723,-0.0059963063023506,0.0225029085369572,-0.0501020070347866,0.0381093944300854,0.789884956421711
CD300E,CMRF35-like molecule 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32723,0.00747871490525571,0.0246113833604479,-0.0407595964812221,0.0557170262917335,0.761232400709301
CD300E,CMRF35-like molecule 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32723,0.021071691905387,0.0381031979559108,-0.0536105760881981,0.0957539598989722,0.580266154226738
CD300E,CMRF35-like molecule 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32723,0.0484540525297799,0.0441625984998353,-0.0381046405298973,0.135012745589457,0.272595167448155
CD300E,CMRF35-like molecule 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32723,0.0220119089971063,0.0254469038242035,-0.0278640224983324,0.0718878404925451,0.387054927758147
CD300E,CMRF35-like molecule 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32723,0.0886872149212844,0.0427182727884468,0.00495940025592867,0.17241502958664,0.0379138742568256
CD300E,CMRF35-like molecule 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32723,0.0188928189187051,0.0329361029469493,-0.0456619428573156,0.0834475806947258,0.566239292204966
CD300E,CMRF35-like molecule 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32727,-0.0345170587125382,0.0443675114750273,-0.121477381203592,0.0524432637785153,0.436601267308939
CD300E,CMRF35-like molecule 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32727,-0.012665593786357,0.0218359443091891,-0.0554640446323677,0.0301328570596538,0.561906314693992
CD300E,CMRF35-like molecule 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32727,-0.0619700659015163,0.0303163025730822,-0.121390018944757,-0.00255011285827531,0.0409714800910885
CD300E,CMRF35-like molecule 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32726,0.0704755552143361,0.0502759310284196,-0.0280652696013663,0.169016380030039,0.161017381546946
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20600.Liking for adding salt to foods,35451,-0.0194480020063015,0.0389049998304131,-0.0957018016739112,0.0568057976613083,0.617165982799434
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20601.Liking for aniseed,35451,-0.0324310032889433,0.0386666996179589,-0.108217734540143,0.0433557279622563,0.401636954333035
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20602.Liking for apple juice,35451,0.116768514823333,0.0391329451310064,0.0400679423665603,0.193469087280105,0.00285200059002033
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20603.Liking for apples,35451,-0.0204275978814622,0.0395822992528212,-0.0980089044169918,0.0571537086540674,0.605809007476013
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20604.Liking for asparagus,35451,-0.190432654266597,0.0394433272353449,-0.267741575647873,-0.113123732885321,1.39669161797977e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20605.Liking for aubergine,35451,-0.229383712955075,0.0388101905968057,-0.305451686524814,-0.153315739385336,3.5089222125649e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20606.Liking for avocados,35451,-0.261973371261251,0.0394148664305696,-0.339226509465167,-0.184720233057334,3.13482540511851e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20607.Liking for bacon,35451,-0.122745405179473,0.0394337068424622,-0.200035470590699,-0.0454553397682473,0.00185834049104108
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35451,-0.177911936448168,0.0394667174502075,-0.255266702650575,-0.100557170245762,6.61154676583238e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20609.Liking for bananas,35451,0.0688801646578035,0.0402297585092591,-0.00997016202034443,0.147730491335951,0.0868922092565298
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35451,-0.145855048286578,0.0392891363882594,-0.222861755607566,-0.0688483409655893,0.000206306057548334
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20611.Liking for beef steak,35451,-0.158678066595427,0.0392812016865162,-0.235669221900999,-0.0816869112898554,5.39012332065325e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20612.Liking for beetroot,35451,-0.0879554976177298,0.0395905509517689,-0.165552977483197,-0.0103580177522628,0.0263276738697662
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20613.Liking for bell pepper,35451,-0.130663355653103,0.0390071335065615,-0.207117337325963,-0.0542093739802424,0.000811487144531559
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20614.Liking for bicycling,35451,-0.0777358451767605,0.038915647568284,-0.154010514410597,-0.00146117594292379,0.0457891149257211
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20615.Liking for biscuits,35451,0.204061644413452,0.0392116378735138,0.127206834181365,0.280916454645538,1.98263347746865e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20616.Liking for bitter foods,35451,-0.20628254259952,0.0389407097239904,-0.282606333658541,-0.129958751540499,1.19649424295934e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20617.Liking for bitter or ale,35451,-0.185526547337281,0.03997441576726,-0.26387640224111,-0.107176692433451,3.50308554966858e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20618.Liking for black olives,35451,-0.214488284351945,0.0390616464915058,-0.291049111475296,-0.137927457228594,4.08047501586256e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20619.Liking for black pepper,35451,-0.135211445919083,0.0393954566938911,-0.212426541039109,-0.0579963507990565,0.000600890596004086
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20620.Liking for blue cheese,35451,-0.236037479189307,0.0393465293105856,-0.313156676638054,-0.158918281740559,2.0454141839605e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20621.Liking for bolognese sauce,35451,-0.0497573585324776,0.0393298930650587,-0.126843948939993,0.0273292318750374,0.205850812384637
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20622.Liking for broad beans,35451,-0.130277988664342,0.0388318052151109,-0.20638832688596,-0.0541676504427246,0.000796399989679823
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20623.Liking for broccoli,35451,-0.0396641846088953,0.0402080246418181,-0.118471912906859,0.0391435436890682,0.323921007584817
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20624.Liking for brown rice,35451,-0.135236728889483,0.0389388808915094,-0.211556935436841,-0.0589165223421245,0.00051645671581082
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20625.Liking for brussel sprouts,35451,-0.125864647336182,0.0390899972020921,-0.202481041852283,-0.0492482528200817,0.00128603173801112
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20626.Liking for burgers (meat),35451,-0.100056396930283,0.038742101388928,-0.175990915652582,-0.0241218782079844,0.00981728020391239
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35451,-0.177459876682447,0.0388063245658402,-0.253520272831494,-0.1013994805334,4.85861347512809e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20628.Liking for butter on bread,35451,0.0238784205036455,0.0394144327578643,-0.0533738677017686,0.10113070870906,0.544639944280132
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20629.Liking for butternut squash,35451,-0.130575793165799,0.0389970405010237,-0.207009992547805,-0.0541415937837925,0.000815530449001405
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20630.Liking for cabbage,35451,-0.0948723401136816,0.039637283293801,-0.172561415369532,-0.0171832648578317,0.016703721815124
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20631.Liking for cake,35451,0.154845727094424,0.0393568544933899,0.0777062922873797,0.231985161901468,8.38906720214796e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20632.Liking for cake icing,35451,0.180674384255068,0.0385853321285291,0.105047133283151,0.256301635226985,2.86667812058669e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20633.Liking for capers,35451,-0.275820889279285,0.0388359528752415,-0.351939356914758,-0.199702421643812,1.29972986653496e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20634.Liking for cauliflower,35451,-0.0825515886918174,0.0395083216489239,-0.159987899123708,-0.00511527825992657,0.0366868915446884
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35451,0.055249500571884,0.0386984876663843,-0.0205995352542293,0.131098536397997,0.153407645055012
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20636.Liking for cheesecake,35451,0.0701032516607958,0.0389034177039285,-0.00614744703890398,0.146353950360496,0.0715742570175475
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20637.Liking for cherries,35451,-0.0737218146461184,0.0406283379441954,-0.153353357016741,0.00590972772450461,0.0696202232422534
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20638.Liking for chicken,35451,-0.0341957483787351,0.0407968748270341,-0.114157623039722,0.0457661262822517,0.401938328447048
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20639.Liking for chilli pepper,35451,-0.207150236929944,0.0389576973387358,-0.283507323713866,-0.130793150146022,1.0727017405478e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20640.Liking for chips or french fries,35451,0.101965621101406,0.0394329589281454,0.0246770216022411,0.179254220600571,0.00972751210957089
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20641.Liking for cigarette smoking,35451,-0.0469040309546336,0.0609927933302158,-0.166449905881857,0.0726418439725895,0.441903415784644
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20642.Liking for cod,35451,-0.122535724853722,0.0401662768495272,-0.201261627478795,-0.0438098222286485,0.00228816123746329
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20643.Liking for coffee with sugar,35451,0.160557134111241,0.0423865699902519,0.077479456930347,0.243634811292135,0.000152679309140246
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20644.Liking for coffee without sugar,35451,-0.279557837424758,0.0395113896629446,-0.357000161164129,-0.202115513685387,1.57643732300374e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20645.Liking for coriander,35451,-0.19601254771194,0.0392028658107339,-0.272850164700978,-0.119174930722901,5.81832714640102e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20646.Liking for corn flakes,35451,0.222710741336042,0.0389759564380081,0.146317866717546,0.299103615954537,1.1303567051495e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20647.Liking for cream,35451,0.018417487313445,0.0388145928691759,-0.0576591147101398,0.0944940893370297,0.635153023539632
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20648.Liking for croissant,35451,0.0350963749868972,0.0387870987050657,-0.0409263384750317,0.111119088448826,0.36556547320789
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20649.Liking for cucumber,35451,-0.0161472687973308,0.0391341450447059,-0.0928501930849544,0.0605556554902928,0.679897591418061
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20650.Liking for curry,35451,-0.112146517752885,0.0396385476202663,-0.189838071088607,-0.0344549644171627,0.00467405507733943
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20651.Liking for dairy products,35451,0.0328340642079279,0.0394493940541368,-0.0444867481381801,0.110154876554036,0.405252020266453
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20652.Liking for dark chocolate,35451,-0.13612312065392,0.03914847324029,-0.212854128204888,-0.0593921131029512,0.000508729995984529
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35451,0.108203743202231,0.0400085034212853,0.029787076496512,0.18662040990795,0.00685033987320359
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20654.Liking for dried fruit,35451,-0.0311701396803197,0.0390763431145776,-0.107759772184892,0.0454194928242525,0.425076691225085
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20655.Liking for eggs,35451,-0.154257206410039,0.0400544816129324,-0.232763990371387,-0.0757504224486917,0.000118180764772127
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20656.Liking for exercising alone,35451,-0.141476414896979,0.0391252393153762,-0.218161883955116,-0.0647909458388417,0.000300474558973842
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20657.Liking for exercising with others,35451,-0.146685468512508,0.0390109198971259,-0.223146871510875,-0.0702240655141417,0.000170672155158072
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35451,-0.133484321118278,0.0394188357197994,-0.210745239129085,-0.0562234031074711,0.000710753098025415
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20659.Liking for fatty foods,35451,0.00233963379709096,0.0387680396565064,-0.0736457239296616,0.0783249915238435,0.951878278869633
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35451,-0.111932173818257,0.0417084655393767,-0.193680766275435,-0.0301835813610786,0.00729202769653255
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20661.Liking for fried chicken,35451,-0.0352747987126971,0.0385707810087362,-0.11087352948982,0.0403239320644258,0.360448441456459
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20662.Liking for fried or battered fish,35451,-0.0778135844829536,0.0389030024913386,-0.154063469365977,-0.00156369959993002,0.0455025357095789
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20663.Liking for fruit,35451,-0.0455056562733416,0.0427171347402606,-0.129231240364252,0.0382199278175691,0.286772009032476
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20664.Liking for garlic,35451,-0.132049608292779,0.0396062165694704,-0.209677792768941,-0.0544214238166169,0.000858559285168418
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20665.Liking for gherkins,35451,-0.151506721029065,0.038798731477685,-0.227552234725328,-0.0754612073328026,9.47835534733145e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20666.Liking for globe artichoke,35451,-0.200919117032733,0.03890453054761,-0.277171996906048,-0.124666237159417,2.45196881100679e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20667.Liking for goat's cheese,35451,-0.147821225612011,0.0387957649601938,-0.223860924933991,-0.0717815262900314,0.000139549218744217
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20668.Liking for going to a cafe,35451,0.0290926197909674,0.0393075810654464,-0.0479502390973077,0.106135478679242,0.459237665508204
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20669.Liking for going to the gym,35451,-0.120016982371394,0.0386045239762425,-0.195681849364829,-0.0443521153779583,0.00188250705080107
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20670.Liking for going to the pub,35451,-0.127069858036808,0.0390192592511622,-0.203547606169086,-0.05059210990453,0.0011308217442482
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20671.Liking for grapefruit,35451,-0.115088066080167,0.0389561205112108,-0.19144206228214,-0.0387340698781939,0.00314009542125561
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20672.Liking for green olives,35451,-0.21118079994492,0.0390829796014733,-0.287783439963808,-0.134578159926032,6.66860846397372e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20673.Liking for haddock,35451,-0.18359690821523,0.0398650224331697,-0.261732352184243,-0.105461464246218,4.15932863295521e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20674.Liking for ham,35451,-0.0734616707171316,0.0391471245517723,-0.150190034838605,0.00326669340434213,0.0606044485964799
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20675.Liking for hard cheese,35451,-0.0291394204025012,0.0398874923843279,-0.107318905475784,0.0490400646707814,0.465074769432814
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20676.Liking for herring,35451,-0.211673885566917,0.0390229471823501,-0.288158862044323,-0.135188909089511,5.93373663634863e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20677.Liking for honey,35451,-0.0014194082855727,0.0389545815493011,-0.0777703881222028,0.0749315715510574,0.970934126555321
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35451,-0.257893847864171,0.0391274573826522,-0.334583664334169,-0.181204031394173,4.55461799426427e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20679.Liking for ice cream,35451,0.0964366434085207,0.0394781885079699,0.0190593939328998,0.173813892884142,0.0145893396537098
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20680.Liking for jam,35451,0.15023162338923,0.0388211423292567,0.0741421844238871,0.226321062354573,0.000109503881769926
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20681.Liking for kiwi fruit,35451,0.0207963748598484,0.0392469715771445,-0.0561276894313548,0.0977204391510517,0.596201941950636
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20682.Liking for lager,35451,-0.145981602214612,0.0390769540049535,-0.222572432064321,-0.0693907723649033,0.000188057492765522
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20683.Liking for lamb,35451,-0.161445785745898,0.0392334961239121,-0.238343438148766,-0.0845481333430305,3.89862051148643e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20684.Liking for lemons,35451,-0.178608459584947,0.0391768822599018,-0.255395148814354,-0.101821770355539,5.1917793436007e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20685.Liking for lentils or beans,35451,-0.0582850031216198,0.0394015018332981,-0.135511946714884,0.0189419404716445,0.13909845943129
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20686.Liking for liver,35451,-0.21147718204769,0.0392914356053692,-0.288488395834213,-0.134465968261166,7.49861801255778e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20687.Liking for mackerel,35451,-0.232525091314713,0.0390290693110731,-0.309022067164416,-0.156028115465009,2.63181780635373e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20688.Liking for marzipan,35451,0.0573225874288901,0.0388722109050187,-0.0188669459449466,0.133512120802727,0.140336048717549
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20689.Liking for mayonnaise,35451,-0.0868520879953777,0.0388637514693939,-0.16302504087539,-0.0106791351153657,0.0254505303581521
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20690.Liking for melon,35451,-0.0157387205341526,0.0403219572087858,-0.0947697566633728,0.0632923155950676,0.696302453218398
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20691.Liking for milk chocolate,35451,0.113338193234755,0.0392064500123533,0.0364935512105429,0.190182835258968,0.00384970894238055
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20692.Liking for mushrooms,35451,-0.133647490465035,0.0403080422992842,-0.212651253371633,-0.0546437275584383,0.000917102608332192
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20694.Liking for orange juice,35451,0.0598806743539974,0.0393765224881852,-0.0172973097228457,0.13705865843084,0.128357357891824
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20695.Liking for oranges,35451,-0.0480602813990206,0.0395383222359741,-0.12555539298153,0.0294348301834885,0.224186239449334
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20696.Liking for pasta,35451,0.0536358846922605,0.0395284027505217,-0.023839784698762,0.131111554083283,0.17484107886895
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20697.Liking for pears,35451,0.0623384536837241,0.0394900333541102,-0.015062011690332,0.13973891905778,0.11445812525997
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20698.Liking for pizza,35451,0.0481208147157122,0.0391135498126637,-0.0285417429171086,0.124783372348533,0.218615375995917
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20699.Liking for plain yogurt,35451,-0.0858752637853615,0.0391217155974537,-0.162553826356371,-0.00919670121435227,0.0281776915391358
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20700.Liking for plums,35451,-0.0291571766513274,0.0399154897605937,-0.107391536582091,0.0490771832794362,0.465116053114442
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20701.Liking for pollock,35451,-0.209089009093391,0.0389529050837934,-0.285436703057626,-0.132741315129156,8.12687395599448e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20702.Liking for pork chop,35451,-0.120374636997012,0.0390018096598096,-0.196818183930239,-0.0439310900637849,0.00203083836074941
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20703.Liking for porridge,35451,0.0267485483881179,0.0395966965809356,-0.0508609769105159,0.104358073686752,0.49935592154915
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20704.Liking for potato crisps,35451,-0.00180983215757914,0.0390158569575859,-0.0782809117944475,0.0746612474792892,0.963002524048951
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20705.Liking for potatoes,35451,0.0777399677087505,0.0396252217755398,7.45330286924806e-05,0.155405402388808,0.0498002575013561
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20706.Liking for prawns,35451,-0.316982640743735,0.0397142210877137,-0.394822514075653,-0.239142767411816,1.58065160829538e-15
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20707.Liking for raw carrots,35451,-0.0438048895667749,0.0395348310997374,-0.12129315852226,0.0336833793887103,0.267881583554103
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20708.Liking for red meat,35451,-0.151305289336046,0.0391193417403046,-0.227979199147043,-0.0746313795250494,0.000110428522037648
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20709.Liking for red wine,35451,-0.303403593053976,0.0394181809765859,-0.380663227768085,-0.226143958339868,1.50548277240227e-14
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35451,0.110833252061179,0.0400099912757209,0.0324136691607662,0.189252834961592,0.00561215689328348
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20711.Liking for roast chicken,35451,-0.0624319453445526,0.0409501214415444,-0.14269418336998,0.0178302926808745,0.127389917647686
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20712.Liking for salad dressing,35451,-0.036025115439257,0.0389941458422,-0.112453641289969,0.0404034104114551,0.355578673349194
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20713.Liking for salad leaves,35451,-0.0740537896860048,0.0400669694944892,-0.152585049895204,0.00447747052319405,0.0645916121947761
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20714.Liking for salami,35451,-0.212582456489914,0.0386918169241471,-0.288418417661243,-0.136746495318586,4.00672573037375e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20715.Liking for salmon,35451,-0.194248252392168,0.0406471719080761,-0.273916709331997,-0.114579795452338,1.784338224706e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20716.Liking for salty foods,35451,-0.054755893177026,0.0386722851035085,-0.130553571979903,0.0210417856258506,0.156833154379622
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20717.Liking for salty pretzels,35451,-0.0634635567349617,0.0389935938008073,-0.139891000584544,0.0129638871146207,0.10365008007124
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20718.Liking for sardines,35451,-0.229730216431999,0.0389358921259717,-0.306044564998904,-0.153415867865095,3.73178935676615e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20719.Liking for sausages (meat),35451,-0.0627104197797768,0.0391515121093494,-0.139447383514102,0.014026543954548,0.109241083515612
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20720.Liking for savoury biscuits,35451,0.0175735047778931,0.0392042811226707,-0.0592668862225415,0.0944138957783278,0.653977746962467
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35451,-0.331319779867508,0.0390672539297463,-0.40789159756981,-0.254747962165205,2.50824628702327e-17
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20722.Liking for skimmed milk,35451,0.0730596871460286,0.0387412545877266,-0.00287317184591555,0.148992546137973,0.0593419396110555
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20723.Liking for smoked fish,35451,-0.214183354465928,0.0389923590854778,-0.290608378273465,-0.137758330658392,4.0360700165931e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20724.Liking for soft cheese,35451,-0.0670636300470475,0.0390199964920626,-0.14354282317149,0.00941556307739529,0.0856959122437207
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20725.Liking for soy sauce,35451,-0.0831641558547652,0.0390945988794713,-0.159789569658529,-0.00653874205100137,0.0334200245083634
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20726.Liking for soya milk,35451,-0.0630775582045354,0.0390916870065871,-0.139697264737446,0.0135421483283754,0.106645834539801
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20727.Liking for spicy foods,35451,-0.153063112214594,0.0391560518052732,-0.229808973752929,-0.0763172506762581,9.31862253919545e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20728.Liking for spinach,35451,-0.201749429926633,0.0393934058605427,-0.278960505413296,-0.124538354439969,3.08147305678764e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20729.Liking for spirits,35451,-0.183104077495256,0.0389569748466976,-0.259459748194784,-0.106748406795729,2.62951390053826e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20730.Liking for strawberries,35451,0.0154740878764236,0.0424984126212509,-0.0678228008612282,0.0987709766140753,0.715782677010819
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35451,0.128302256702665,0.039727486036399,0.0504363840713227,0.206168129334007,0.00124327101610957
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20732.Liking for sweet foods,35451,0.244145787465641,0.0390808348315456,0.167547351195811,0.32074422373547,4.32530523833785e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20733.Liking for taking the stairs,35451,-0.195647801099387,0.0399033663011043,-0.273858399049552,-0.117437203149223,9.56451917776255e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20734.Liking for tea with sugar,35451,0.230786255975578,0.0464699095860216,0.139705233186975,0.32186727876418,6.9194495670127e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20735.Liking for tea without sugar,35451,-0.0546140984517823,0.0406268060594738,-0.134242638328351,0.0250144414247865,0.178881837211803
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20736.Liking for tomato ketchup,35451,0.0518394587778345,0.0388866589563918,-0.0243783927766934,0.128057310332362,0.182528131941945
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20737.Liking for tinned tuna,35451,-0.0620321203684619,0.0392148701860401,-0.138893265933101,0.0148290251961767,0.11371066885937
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20738.Liking for turnip (white),35451,-0.0770704398242703,0.0387858371001818,-0.153090680540627,-0.00105019910791393,0.0469373968050844
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20739.Liking for vegetables,35451,-0.0958125105878078,0.0428608515613905,-0.179819779648133,-0.0118052415274825,0.0254079957603546
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20740.Liking for vinegar,35451,-0.0449504379484074,0.0391304620283296,-0.121646143523933,0.0317452676271187,0.250689976149316
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20741.Liking for watching television,35451,0.123646206096307,0.0391735174984607,0.0468661117993242,0.20042630039329,0.0016015421122554
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20742.Liking for whisky,35451,-0.207455486628659,0.0405865014745368,-0.287005029518751,-0.127905943738567,3.24810376084174e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20743.Liking for white bread,35451,0.112109510621617,0.0387169648784229,0.0362242594599084,0.187994761783326,0.00379121222129972
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20744.Liking for white rice,35451,0.0503728642867358,0.0390795974756921,-0.0262231467656207,0.126968875339092,0.197430385469001
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20745.Liking for white wine,35451,-0.228531990487968,0.0388617787245793,-0.304701076788144,-0.152362904187793,4.19976094162518e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35451,-0.00977651894285558,0.0394322540908597,-0.0870637369609405,0.0675106990752293,0.804191389626496
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20747.Liking for whole milk,35451,0.0398849771955349,0.0389288013150509,-0.0364154733819648,0.116185427773035,0.305591219698439
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20748.Liking for wholemeal bread,35451,-0.042427786770887,0.0405637478340357,-0.121932732525597,0.037077158983823,0.295604412407983
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20749.Liking for working up a sweat,35451,-0.166756730084804,0.0389836719117498,-0.243164727031833,-0.0903487331377742,1.90431495638688e-05
CD300E,CMRF35-like molecule 2,Physical measures,X21001.Body mass index (BMI),52205,-0.033180011953381,0.0108480095322256,-0.0544421106365432,-0.0119179132702188,0.00222561376628034
CD300E,CMRF35-like molecule 2,Physical measures,X21002.Weight,52226,0.0154486035631471,0.0063374323634485,0.00302723613078802,0.0278699709955061,0.0147881359519979
CD300E,CMRF35-like molecule 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33087,0.0117174258216963,0.00491810406134703,0.00207794186145607,0.0213569097819364,0.0172152561101173
CD300E,CMRF35-like molecule 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34806,0.0261174955405002,0.0414273185759442,-0.0550800488683503,0.107315039949351,0.528419017212459
CD300E,CMRF35-like molecule 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34806,-0.0214991916066279,0.0433783508381321,-0.106520759249367,0.0635223760361109,0.620172274636972
CD300E,CMRF35-like molecule 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34806,-0.0155650601890045,0.0427799875151169,-0.0994138357186336,0.0682837153406247,0.715984702879739
CD300E,CMRF35-like molecule 2,Health and medical history,X21040.Satisfaction with bowel habits,34776,0.0567720391289647,0.0398918190863309,-0.0214159262802439,0.134960004538173,0.154721301479868
CD300E,CMRF35-like molecule 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34773,0.078440333837441,0.0420999348851392,-0.0040755385374318,0.160956206212314,0.0624618826830838
CD300E,CMRF35-like molecule 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34764,0.0193154231499807,0.0430959426169951,-0.0651526243793297,0.103783470679291,0.654020754708241
CD300E,CMRF35-like molecule 2,Health and medical history,X21043.Least number of times bowels opened per week,34706,-0.0542136011260846,0.0422804216929094,-0.137083227644187,0.0286560253920178,0.199786264164895
CD300E,CMRF35-like molecule 2,Health and medical history,X21044.Average number of times bowels opened per day,34737,0.108008986158633,0.0474521581727605,0.0150027561400222,0.201015216177243,0.0228554429147542
CD300E,CMRF35-like molecule 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34811,-0.070546288437501,0.0434072785623609,-0.155624554419728,0.0145319775447264,0.104144905225292
CD300E,CMRF35-like molecule 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34806,-0.0560774601274317,0.0434780289923131,-0.141294396952365,0.029139476697502,0.197151367157823
CD300E,CMRF35-like molecule 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30262,0.177171859901536,0.0649225168901522,0.0499237267968373,0.304419993006234,0.00637052790951576
CD300E,CMRF35-like molecule 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34808,-0.0745834648927678,0.0456566711977974,-0.164070540440451,0.0149036106549151,0.102377484178127
CD300E,CMRF35-like molecule 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34806,-0.099452279581378,0.0645708631963074,-0.226011171446141,0.0271066122833846,0.123539627743296
CD300E,CMRF35-like molecule 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34809,-0.107731777526752,0.0514840089971109,-0.20864043516109,-0.00682311989241462,0.0364141948198013
CD300E,CMRF35-like molecule 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34807,-0.193890858318009,0.124504788996134,-0.437920244750431,0.0501385281144136,0.119429042640655
CD300E,CMRF35-like molecule 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34809,-0.0788353291167289,0.0488155238390133,-0.174513755841195,0.0168430976077371,0.106347238849146
CD300E,CMRF35-like molecule 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34809,-0.267994194193674,0.0505970747444225,-0.367164460692742,-0.168823927694606,1.20243771657633e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34558,0.133075180156327,0.0451252806927265,0.0446296299985826,0.22152073031407,0.0031947717452607
CD300E,CMRF35-like molecule 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34809,-0.00425197404040549,0.0449756064401962,-0.0924041626631901,0.0839002145823792,0.924682288997463
CD300E,CMRF35-like molecule 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34810,-0.00906715072135271,0.0618884895745492,-0.130368590287469,0.112234288844764,0.883523175674274
CD300E,CMRF35-like molecule 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34808,-0.187171822706548,0.0431717491054803,-0.27178845095329,-0.102555194459807,1.46718601408094e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34806,0.00451984850344019,0.0432079748275631,-0.0801677821585834,0.0892074791654638,0.916689725870854
CD300E,CMRF35-like molecule 2,Working and living environment,X21100.Water hardness (USGS classification),51965,-0.0215727821394452,0.0259812864178623,-0.0724961035184553,0.0293505392395649,0.406364927948325
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2139.Age first had sexual intercourse,49235,7.85796856345897e-05,0.00291442102369103,-0.00563368552079984,0.00579084489206901,0.978489962904704
CD300E,CMRF35-like molecule 2,Health and medical history,X2149.Lifetime number of sexual partners,47223,-0.115103415558517,0.0293055635469795,-0.172542320110597,-0.0576645110064377,8.60090408054351e-05
CD300E,CMRF35-like molecule 2,Physical activities,X22032.IPAQ activity group,47188,-0.235520627618058,0.0284922667335366,-0.29136547041579,-0.179675784820326,1.45681646965675e-16
CD300E,CMRF35-like molecule 2,Physical activities,X22033.Summed days activity,47776,-0.0241347982607417,0.00279612129591666,-0.0296151960007383,-0.018654400520745,6.4245960634127e-18
CD300E,CMRF35-like molecule 2,Physical activities,X22034.Summed minutes activity,47188,-0.0199261667755959,0.00286156062357593,-0.0255348255978047,-0.0143175079533871,3.40992111772134e-12
CD300E,CMRF35-like molecule 2,Physical activities,X22037.MET minutes per week for walking,46409,-0.0124312589466747,0.00280704172939827,-0.0179330607362953,-0.00692945715705408,9.52934747580459e-06
CD300E,CMRF35-like molecule 2,Physical activities,X22038.MET minutes per week for moderate activity,47188,-0.0167291105401114,0.00292918746602378,-0.022470317973518,-0.0109879031067048,1.13560597207608e-08
CD300E,CMRF35-like molecule 2,Physical activities,X22039.MET minutes per week for vigorous activity,47188,-0.275726115910106,0.0286108765819446,-0.331803434010717,-0.219648797809495,6.12398911100626e-22
CD300E,CMRF35-like molecule 2,Physical activities,X22040.Summed MET minutes per week for all activity,46409,-0.0221163080049108,0.00288767053876578,-0.0277761422608917,-0.0164564737489299,1.95100815523453e-14
CD300E,CMRF35-like molecule 2,Eye measures,X2217.Age started wearing glasses or contact lenses,46558,-0.00372778849910451,0.00335707511032729,-0.010307655715346,0.00285207871713697,0.266826619534582
CD300E,CMRF35-like molecule 2,Working and living environment,X22501.Year ended full time education,31413,-0.049419155780726,0.0139861761856683,-0.0768320611046358,-0.0220062504568162,0.000412658856879358
CD300E,CMRF35-like molecule 2,Lifestyle factors,X22506.Tobacco smoking,31363,-0.182841817798486,0.101599908733529,-0.381977638916202,0.0162940033192309,0.0719599141507629
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50273,-0.207705698044881,0.0582671074830958,-0.321909228711748,-0.0935021673780128,0.000364892832355461
CD300E,CMRF35-like molecule 2,Physical measures,X23098.Weight,51848,0.0171650189206575,0.00636380050075979,0.00469196993916827,0.0296380679021466,0.00699481123271439
CD300E,CMRF35-like molecule 2,Physical measures,X23099.Body fat percentage,51826,0.0751355562200254,0.00613860066479576,0.0631038989170257,0.0871672135230251,2.33135947410804e-34
CD300E,CMRF35-like molecule 2,Physical measures,X23100.Whole body fat mass,51789,0.0595198552727117,0.0058423684603665,0.0480688130903934,0.0709708974550301,2.48394726209381e-24
CD300E,CMRF35-like molecule 2,Physical measures,X23101.Whole body fat-free mass,51843,-0.0302612717548052,0.00543428490396625,-0.0409124701665791,-0.0196100733430314,2.5917360504927e-08
CD300E,CMRF35-like molecule 2,Physical measures,X23102.Whole body water mass,51848,-0.0304553051641585,0.00543307171994715,-0.0411041257352549,-0.019806484593062,2.0955943593981e-08
CD300E,CMRF35-like molecule 2,Physical measures,X23104.Body mass index (BMI),51848,-0.0295707124019617,0.0109062456223466,-0.0509469538217611,-0.00819447098216233,0.00670495640378413
CD300E,CMRF35-like molecule 2,Physical measures,X23105.Basal metabolic rate,51846,-0.0235055206842205,0.00582645699509188,-0.0349253763946006,-0.0120856649738405,5.49168507610747e-05
CD300E,CMRF35-like molecule 2,Physical measures,X23106.Impedance of whole body,51845,0.0686627580569313,0.00444846177637816,0.0599437729752301,0.0773817431386325,1.57874543363317e-53
CD300E,CMRF35-like molecule 2,Physical measures,X23107.Impedance of leg (right),51845,0.0257744102869039,0.00367725640205296,0.0185669877388801,0.0329818328349277,2.45218040594671e-12
CD300E,CMRF35-like molecule 2,Physical measures,X23108.Impedance of leg (left),51844,0.0261434174145772,0.00365107467987958,0.0189873110420132,0.0332995237871411,8.23827865191251e-13
CD300E,CMRF35-like molecule 2,Physical measures,X23109.Impedance of arm (right),51838,0.0753035175477671,0.0044603468048509,0.0665612378102593,0.0840457972852748,1.24299910452221e-63
CD300E,CMRF35-like molecule 2,Physical measures,X23110.Impedance of arm (left),51843,0.0766210674192355,0.00445318093644998,0.0678928327837935,0.0853493020546774,5.24447460477853e-66
CD300E,CMRF35-like molecule 2,Physical measures,X23111.Leg fat percentage (right),51844,0.0219897697406341,0.00760955528853422,0.00707504137510704,0.0369044981061612,0.00385835157491381
CD300E,CMRF35-like molecule 2,Physical measures,X23112.Leg fat mass (right),51843,0.0252012457243353,0.00789815930177062,0.00972085349286493,0.0406816379558058,0.0014204852610003
CD300E,CMRF35-like molecule 2,Physical measures,X23113.Leg fat-free mass (right),51843,-0.00734701705556578,0.00584376731841542,-0.01880080099966,0.00410676688852844,0.208677295879979
CD300E,CMRF35-like molecule 2,Physical measures,X23114.Leg predicted mass (right),51842,-0.00665479415434761,0.00586616472998103,-0.0181524770251104,0.0048428887164152,0.256621015826433
CD300E,CMRF35-like molecule 2,Physical measures,X23115.Leg fat percentage (left),51841,0.0246577316881619,0.00787667701152654,0.00921944474556983,0.0400960186307539,0.00174704054015746
CD300E,CMRF35-like molecule 2,Physical measures,X23116.Leg fat mass (left),51841,0.0329600878506852,0.00821107680650011,0.0168663773099449,0.0490537983914254,5.98283044456847e-05
CD300E,CMRF35-like molecule 2,Physical measures,X23117.Leg fat-free mass (left),51839,-0.00558560587758044,0.00606309252458402,-0.0174692672257651,0.00629805547060423,0.356929421421634
CD300E,CMRF35-like molecule 2,Physical measures,X23118.Leg predicted mass (left),51838,-0.00525070562855294,0.0060856010583173,-0.0171784837028548,0.00667707244574896,0.388250403894859
CD300E,CMRF35-like molecule 2,Physical measures,X23119.Arm fat percentage (right),51838,0.070579359493175,0.00677629327657571,0.0572978246710866,0.0838608943152633,2.34120388124997e-25
CD300E,CMRF35-like molecule 2,Physical measures,X23120.Arm fat mass (right),51835,0.0546479174219623,0.00663039229173844,0.041652348530155,0.0676434863137697,1.76636650485162e-16
CD300E,CMRF35-like molecule 2,Physical measures,X23121.Arm fat-free mass (right),51835,-0.0365610783089007,0.00543743319779903,-0.0472184473765867,-0.0259037092412146,1.80252961478865e-11
CD300E,CMRF35-like molecule 2,Physical measures,X23122.Arm predicted mass (right),51834,-0.0373215213605641,0.00543958536139367,-0.0479831086688957,-0.0266599340522325,6.97572038014061e-12
CD300E,CMRF35-like molecule 2,Physical measures,X23123.Arm fat percentage (left),51830,0.0768229233285465,0.00692428696822472,0.063251320870826,0.090394525786267,1.52674044669553e-28
CD300E,CMRF35-like molecule 2,Physical measures,X23124.Arm fat mass (left),51829,0.0541411986104916,0.0066002653351753,0.041204678553548,0.0670777186674352,2.44659925428303e-16
CD300E,CMRF35-like molecule 2,Physical measures,X23125.Arm fat-free mass (left),51825,-0.0354579283894266,0.00552361626550288,-0.0462842162698122,-0.0246316405090409,1.39066216942041e-10
CD300E,CMRF35-like molecule 2,Physical measures,X23126.Arm predicted mass (left),51824,-0.0362596914672273,0.00555005874617128,-0.047137806609723,-0.0253815763247316,6.54808078934979e-11
CD300E,CMRF35-like molecule 2,Physical measures,X23127.Trunk fat percentage,51821,0.0616823079852032,0.00440077033938494,0.0530567981200088,0.0703078178503977,1.7541816490439e-44
CD300E,CMRF35-like molecule 2,Physical measures,X23128.Trunk fat mass,51817,0.0561740830066404,0.00480504844948136,0.0467561880456569,0.0655919779676239,1.68502469638343e-31
CD300E,CMRF35-like molecule 2,Physical measures,X23129.Trunk fat-free mass,51811,-0.0367245401398442,0.00494883486931626,-0.046424256483704,-0.0270248237959843,1.19687110182138e-13
CD300E,CMRF35-like molecule 2,Physical measures,X23130.Trunk predicted mass,51809,-0.0369494345511417,0.00494134059874427,-0.0466344621246805,-0.027264406977603,7.79052144724383e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23400.Total Cholesterol,39991,-0.0279348040194946,0.00373278480870185,-0.0352510622445502,-0.020618545794439,7.60169537664336e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39991,-0.00940264380345829,0.00362911099572314,-0.0165157013550756,-0.00228958625184095,0.00958129865014113
CD300E,CMRF35-like molecule 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39991,0.00129787834410529,0.00364619591514241,-0.00584866564957384,0.00844442233778443,0.721879602971409
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23403.VLDL Cholesterol,39991,0.0232623722852134,0.00358978928297967,0.0162263852905733,0.0302983592798536,9.42871076740093e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39991,-0.0197554471657591,0.00362291788125532,-0.0268563662130195,-0.0126545281184987,5.02804639157839e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23405.LDL Cholesterol,39991,-0.0183844831993038,0.00359370167425673,-0.025428138480847,-0.0113408279177606,3.16078468315851e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23406.HDL Cholesterol,39991,-0.0727839159043961,0.00406261290324149,-0.0807466371947494,-0.0648211946140428,4.35457807984391e-71
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23407.Total Triglycerides,39991,0.0328840670861457,0.00367562972390057,0.0256798328273006,0.0400883013449908,4.06053328905457e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23408.Triglycerides in VLDL,39991,0.0300298275829486,0.00373651457497305,0.0227062590160014,0.0373533961498957,9.85082904677995e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23409.Triglycerides in LDL,39991,0.040004582821977,0.00350385625380485,0.0331370245645195,0.0468721410794345,4.47123968762716e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23410.Triglycerides in HDL,39991,0.0286527707593373,0.00347222522422214,0.0218472093198619,0.0354583321988127,1.67701056613604e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39991,-0.0271689956972612,0.00369721112452725,-0.0344155295013346,-0.0199224618931878,2.10019893252153e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23412.Phospholipids in VLDL,39991,0.0304866481018249,0.00362445239239451,0.0233827214127316,0.0375905747909181,4.38754747130222e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23413.Phospholipids in LDL,39991,-0.0156826811331252,0.00359714332345074,-0.0227330820470886,-0.00863228021916173,1.31011462583772e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23414.Phospholipids in HDL,39991,-0.0549957356988338,0.00382998026106903,-0.0625024970105291,-0.0474889743871385,1.80257900703664e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23415.Total Esterified Cholesterol,39991,-0.0325067362430971,0.00374407019323142,-0.0398451138218307,-0.0251683586643635,4.24818665506945e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39991,0.0207438643939439,0.0035907191883231,0.0137060547848307,0.0277816740030572,7.74097836771698e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39991,-0.0153579165637174,0.00358126653190257,-0.0223771989662465,-0.0083386341611884,1.81008004053394e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39991,-0.0762023990009609,0.00405109534161673,-0.0841425458705297,-0.0682622521313921,4.25358848372964e-78
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23419.Total Free Cholesterol,39991,-0.0161107846115371,0.00370063227788877,-0.0233640238761991,-0.00885754534687514,1.34792536083571e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39991,0.0261132439817722,0.00360867789481302,0.0190402353079387,0.0331862526556057,4.82064504583357e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23421.Free Cholesterol in LDL,39991,-0.0259942618296833,0.00363398133053081,-0.0331168652375237,-0.018871658421843,8.84788477825642e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23422.Free Cholesterol in HDL,39991,-0.0555265856968654,0.00404521645950927,-0.0634552099575036,-0.0475979614362272,1.22362596213993e-42
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39991,-0.0129292935833298,0.00360805606331245,-0.0200010834674222,-0.00585750369923745,0.000340083159104317
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23424.Total Lipids in VLDL,39991,0.029315412457225,0.00365895509220328,0.0221438604765066,0.0364869644379434,1.20553641494221e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23425.Total Lipids in LDL,39991,-0.0145957008743854,0.00359047582879594,-0.0216330334988255,-0.00755836824994537,4.82362361020854e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23426.Total Lipids in HDL,39991,-0.0598318596644319,0.00391038502972809,-0.067496214322699,-0.0521675050061649,1.76541112533141e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39991,-0.0626027633176141,0.0036824323198903,-0.0698203306645991,-0.0553851959706291,2.95826105944881e-64
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23428.Concentration of VLDL Particles,39991,0.0290911010889596,0.00357833184723281,0.0220775706683833,0.0361046315095359,4.60991651237425e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23429.Concentration of LDL Particles,39991,0.00262335623172365,0.00360098047331973,-0.00443456549598301,0.00968127795943031,0.466311014376018
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23430.Concentration of HDL Particles,39991,-0.0667898851758898,0.0036780915441071,-0.0739989446023397,-0.0595808257494399,5.82161899419545e-73
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39991,0.0200092164864907,0.00393123403547683,0.0123039977769562,0.0277144351960253,3.62461000589953e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39991,-0.0171803336875844,0.00359087107972268,-0.0242184410038408,-0.0101422263713279,1.72975787324374e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39991,-0.0256229301082756,0.00416164887929079,-0.0337797619116855,-0.0174660983048656,7.59302064556127e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23434.Phosphoglycerides,39979,-0.0308368417402546,0.00365442801744326,-0.0379995206544434,-0.0236741628260658,3.49270177905572e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39979,0.0569830776193513,0.00391897572528902,0.0493018851977848,0.0646642700409178,1.34678709771016e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23436.Total Cholines,39979,-0.0335966421116317,0.00371493278817403,-0.0408779103764528,-0.0263153738468106,1.68418059531319e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23437.Phosphatidylcholines,39979,-0.0369206300558297,0.00370415429259551,-0.0441807724693169,-0.0296604876423425,2.47423572638305e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23438.Sphingomyelins,39978,-0.0244453071456093,0.00383690826800727,-0.0319656473509035,-0.016924966940315,1.92773018497087e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23439.Apolipoprotein B,39991,0.00474283381580821,0.00361298677631766,-0.0023386202657744,0.0118242878973908,0.189296568360106
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23440.Apolipoprotein A1,39991,-0.0614557670128101,0.00379832504192812,-0.0689004840949892,-0.054011049930631,2.02181415885617e-58
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39991,0.0361129466887617,0.0036015450975838,0.0290539182974974,0.0431719750800259,1.3589414787608e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23442.Total Fatty Acids,39979,0.00837353147112024,0.00351773270491279,0.00147877536949117,0.0152682875727493,0.0173064680252968
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23443.Degree of Unsaturation,39979,-0.0631948623816122,0.00386770244207911,-0.0707755591680873,-0.0556141655951372,1.5644527343166e-59
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39979,-0.0372231442009108,0.00356210113436618,-0.0442048624242685,-0.0302414259775531,1.77163442688513e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39979,-0.0055815635735245,0.00356914564727031,-0.0125770890421743,0.0014139618951253,0.117875381408152
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39979,-0.0140421549016633,0.00356972161123531,-0.0210388092596845,-0.00704550054364213,8.40044136369612e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39979,0.0335558140342813,0.00357092208272244,0.0265568067521453,0.0405548213164173,6.35261812523188e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23448.Saturated Fatty Acids,39979,0.00641820384003354,0.0035360213212547,-0.000512397949625681,0.0133488056296928,0.0695283561226278
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23449.Linoleic Acid,39979,0.000388570057567078,0.00359540244883068,-0.00665841874214106,0.00743555885727522,0.913938219803958
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23450.Docosahexaenoic Acid,39979,-0.0629690145991194,0.0037019525688326,-0.0702248416340313,-0.0557131875642075,2.53396591756343e-64
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39979,-0.0513782471435104,0.00359278049492477,-0.058420096913563,-0.0443363973734578,4.16439560730126e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39979,-0.0295891627873232,0.00367859519124021,-0.036799209362154,-0.0223791162124924,9.32548118372972e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39979,-0.0538241671581892,0.00381063700350558,-0.0612930156850601,-0.0463553186313182,4.96432231581899e-45
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39979,0.0802952528176505,0.00386570718056577,0.0727184667437416,0.0878720388915594,1.36384814646989e-94
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39979,-0.0033714897076954,0.00352765763872422,-0.0102856986795949,0.00354271926420408,0.339222783712799
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39979,-0.0160021252348425,0.00377066166194038,-0.0233926220922457,-0.00861162837743937,2.20944838798315e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39979,-0.0713790136458009,0.00373989794833345,-0.0787092136245344,-0.0640488136670673,2.54409949525688e-80
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39979,-0.0723067542303356,0.00387247001839385,-0.0798967954663875,-0.0647167129942836,5.4237713472222e-77
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39977,0.0400858812742134,0.00357123571850462,0.0330862592659443,0.0470855032824825,3.95784330111243e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23460.Alanine,39987,-0.0120487514601684,0.00348565007081725,-0.0188806255989702,-0.00521687732136657,0.000548297784987523
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23461.Glutamine,39952,-0.00710194081414162,0.00344513140481579,-0.0138543983675806,-0.000349483260702665,0.0392768546254825
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23462.Glycine,39972,0.0127396790813221,0.00362056837520332,0.00564336506592356,0.0198359930967206,0.000434868714010809
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23463.Histidine,39973,-0.0315443597222877,0.00343337070036967,-0.0382737662950122,-0.0248149531495632,4.49748527571107e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39979,-0.0173467464555314,0.0036720278929585,-0.0245439211257301,-0.0101495717853328,2.33173414703924e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23465.Isoleucine,39989,-0.00747933885988591,0.00358217519245412,-0.014500402237096,-0.000458275482675846,0.0368196017484757
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23466.Leucine,39990,-0.0165094384530897,0.00369407857309926,-0.0237498324563643,-0.00926904444981518,7.90610341173746e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23467.Valine,39979,-0.0200562800169414,0.00365537907737887,-0.027220823008604,-0.0128917370252789,4.15483448474795e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23468.Phenylalanine,39987,0.0239781319691403,0.00347705524481473,0.0171631036893034,0.0307931602489772,5.54324553575141e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23469.Tyrosine,39974,0.00293033764799771,0.00355437836497534,-0.00403624394735395,0.00989691924334938,0.409707238976421
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23470.Glucose,39963,-0.0252105236400259,0.00354432466787412,-0.0321573999890592,-0.0182636472909927,1.1838692730739e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23471.Lactate,39963,0.0290149606903154,0.0034827272540085,0.0221888152724587,0.035841106108172,8.64782500315715e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23472.Pyruvate,39948,0.0220900147213536,0.00344228660501612,0.015343132975522,0.0288368964671852,1.42636976555154e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23473.Citrate,39990,0.0276263620566032,0.00352297525798132,0.0207213305509599,0.0345313935622466,4.71874007022663e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39734,0.0316134145801181,0.00341663516786132,0.0249168096511099,0.0383100195091263,2.46020913802743e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23475.Acetate,39978,-0.0289777116779107,0.00348313533694987,-0.0358046569383324,-0.022150766417489,9.53849723374237e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23476.Acetoacetate,39991,0.00449871430062448,0.0034155706338398,-0.00219580414170153,0.0111932327429505,0.187817318595349
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23477.Acetone,39991,-0.00983196762174892,0.0034378561173422,-0.0165701656117396,-0.00309376963175821,0.00424301736639178
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23478.Creatinine,39566,0.109590076393547,0.00421577811801513,0.101327151282237,0.117853001504856,6.71374923930137e-146
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23479.Albumin,39990,-0.0799124947500607,0.00348259416061485,-0.0867383793048658,-0.0730866101952555,1.09438545200426e-114
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23480.Glycoprotein Acetyls,39991,0.0985727407795136,0.00362653620406117,0.0914647298195537,0.105680751739473,4.10025735874326e-159
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39991,0.037876335621038,0.00371378914306519,0.0305973089006303,0.0451553623414458,2.37879229434678e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39991,0.0342786153675676,0.00373325352977244,0.0269614384492137,0.0415957922859216,4.73622038149929e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39991,0.0391427885943089,0.00373288412823878,0.0318263357029609,0.0464592414856569,1.21212263776873e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39991,0.0397814090060098,0.00370395972524011,0.0325216479445392,0.0470411700674804,8.11696284337004e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39991,0.0400659006508823,0.00371871741830799,0.0327772145109986,0.0473545867907659,5.63514423957457e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39991,0.037179012739527,0.00367559764852952,0.0299748413484091,0.0443831841306448,5.58355532599463e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39991,0.0292280793397022,0.00372991574789137,0.0219174444738351,0.0365387142055693,4.93489680681181e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39991,0.0349482309787484,0.0037819013316847,0.0275357043686464,0.0423607575888504,2.74249309810409e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39991,0.0329018556110913,0.00378776859570033,0.0254778291635187,0.040325882058664,4.09657546419627e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39991,0.0358174339686888,0.0037611241801782,0.0284456305755395,0.0431892373618381,1.9144375734053e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39991,0.0338673744276194,0.00370694335635215,0.0266017654491692,0.0411329834060696,7.22197269485847e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39991,0.0313861494941301,0.00367477406859916,0.0241835923196758,0.0385887066685845,1.44825799189612e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39991,0.0354799127887441,0.00373213762695343,0.0281649230399154,0.0427949025375728,2.24111690167637e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39991,0.0305720920899998,0.00382271855758063,0.0230795637171417,0.0380646204628578,1.3555348186021e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39991,0.0319564260616341,0.00374311891363915,0.0246199129909014,0.0392929391323669,1.49380473968188e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39991,0.0275704541137685,0.00374965124802635,0.0202211376676369,0.0349197705599002,2.03401191943134e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39991,0.0343021735382777,0.00376573690601213,0.0269213292024939,0.0416830178740614,9.26921835957467e-20
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39991,0.0314185975018172,0.00368284494454786,0.0242002214105034,0.038636973593131,1.57723161303318e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39991,0.0301581613972733,0.00362369005633717,0.0230557288868525,0.0372605939076942,9.29527016363015e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39991,0.032159595155499,0.00374969366477158,0.0248101955725467,0.0395089947384513,1.06486735315487e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39991,0.0208101239429199,0.00377356375050578,0.0134139389919285,0.0282063088939112,3.54714908783593e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39991,0.0142685507490012,0.00358741468075373,0.00723721797472389,0.0212998835232785,6.99797208905675e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39991,0.0157839796772836,0.00360080408878941,0.00872640366325632,0.0228415556913108,1.1754769034254e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39991,0.0139679253975766,0.00358670141940473,0.00693799061554329,0.0209978601796098,9.88530233648736e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39991,0.00296662532280488,0.00362331273470606,-0.00413506763721901,0.0100683182828288,0.412935170255244
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39991,-0.0031406124974799,0.00366584673169054,-0.0103256720915934,0.00404444709663355,0.39161112470254
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39991,0.010834866249367,0.00358585463918283,0.00380659115656869,0.0178631413421654,0.00251872013827284
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39991,0.0213832502651896,0.00368986702470059,0.0141511108967764,0.0286153896336027,6.95427869735353e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39991,0.0342546341616172,0.00359197013848726,0.0272143726901822,0.0412948956330523,1.6841316848872e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39991,0.0306865512878989,0.00358542943014203,0.0236591096048205,0.0377139929709772,1.24313005372062e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39991,0.0205855552789372,0.0035666626666744,0.0135948964522554,0.027576214105619,7.99367257727786e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39991,0.0228697171075739,0.00357277340590057,0.0158670812320088,0.0298723529831391,1.58509086354376e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39991,0.028972414383186,0.00357607526939584,0.0219633068551702,0.0359815219112018,5.80285284400952e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39991,0.0117920819349855,0.003577332419647,0.00478051039247739,0.0188036534774936,0.000981670544913866
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39991,0.0373565079262607,0.00362542410447545,0.0302506766814888,0.0444623391710326,8.06636365929942e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39991,0.0294790103036123,0.00358973996355959,0.0224431199750355,0.0365149006321891,2.33822480951619e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39991,0.0298271810097597,0.0035797190594485,0.0228109316532406,0.0368434303662787,8.56232683389294e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39991,0.0379091100456658,0.00355342284665589,0.0309444012662202,0.0448738188251113,1.75445089838421e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39991,0.0128295207197144,0.00371995909755754,0.00553840088850162,0.0201206405509272,0.000564451205644063
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39991,0.005824347267517,0.00377037865857071,-0.00156559490328158,0.0132142894383156,0.12242284307962
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39991,0.0279878937854191,0.00360709986928785,0.0209179780416149,0.0350578095292233,9.0622259543291e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39991,0.0475668811305981,0.00351405083759079,0.0406793414889201,0.054454420772276,1.61152745113892e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23523.Concentration of IDL Particles,39991,-0.00237110591137362,0.00369317992799414,-0.00960973857024213,0.00486752674749489,0.520867468612251
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23524.Total Lipids in IDL,39991,-0.0160289238616191,0.00377583308713833,-0.0234295567124102,-0.00862829101082793,2.19682948636209e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23525.Phospholipids in IDL,39991,-0.00724977175740401,0.00377719001933133,-0.0146530641952934,0.00015352068048539,0.0549569357247038
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23526.Cholesterol in IDL,39991,-0.0253640644055513,0.00379563901973492,-0.0328035168842318,-0.0179246119268709,2.42718766094071e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39991,-0.0279792951504824,0.00378864330017271,-0.0354050360188209,-0.0205535542821439,1.59844623584931e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23528.Free Cholesterol in IDL,39991,-0.0171603079660697,0.00379923598401726,-0.0246068104947435,-0.00971380543739584,6.32327046917908e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23529.Triglycerides in IDL,39991,0.0447375219864751,0.00346870323954401,0.0379388636369688,0.0515361803359813,7.15674657403144e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39991,0.00135060015502804,0.00360652712284803,-0.00571819300575409,0.00841939331581018,0.708046406352188
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23531.Total Lipids in Large LDL,39991,-0.0190310636787591,0.00361697599930605,-0.026120336637399,-0.0119417907201193,1.44637590140776e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23532.Phospholipids in Large LDL,39991,-0.0206713497130735,0.0036287641113551,-0.0277837273713295,-0.0135589720548175,1.24405683397254e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23533.Cholesterol in Large LDL,39991,-0.0227611231988041,0.00362178031925956,-0.0298598126245529,-0.0156624337730554,3.37326587415118e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39991,-0.0207103643687296,0.0036020374494552,-0.0277703577696618,-0.0136503709677974,9.10593397069112e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39991,-0.0279013382620927,0.00368060680936149,-0.0351153276084412,-0.0206873489157442,3.6251918793738e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23536.Triglycerides in Large LDL,39991,0.0394946087935659,0.00348340701513301,0.0326671310439052,0.0463220865432266,1.1027614134965e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39991,0.00145541435985265,0.003585311996109,-0.00557179715252099,0.0084826258722263,0.684793544955153
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39991,-0.00884647557014965,0.00356627322572007,-0.015836371092561,-0.0018565800477383,0.0131264911995318
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39991,-0.0111194778618323,0.00355874750765697,-0.0180946229768399,-0.00414433274682461,0.00178394020406369
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39991,-0.0115137795869421,0.00356758279867757,-0.0185062418723501,-0.00452131730153407,0.00125199228387677
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39991,-0.00690326115119985,0.00357380583910321,-0.0139079205958421,0.00010139829344245,0.0534230105297263
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39991,-0.0231333234984062,0.00356388462426915,-0.0301185373619737,-0.0161481096348386,8.77318301007019e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39991,0.0392777469851065,0.00353305529702889,0.0323529586029299,0.0462025353672832,1.31419732874951e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39991,0.0101463182103683,0.00359819630213215,0.0030938534581893,0.0171987829625473,0.00481070080484842
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23545.Total Lipids in Small LDL,39991,-0.00270635398029043,0.0035908435653299,-0.00974440736833703,0.00433169940775618,0.45105122330565
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23546.Phospholipids in Small LDL,39991,-0.00239202404486127,0.00359569371088861,-0.00943958371820294,0.00465553562848039,0.505902107367714
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23547.Cholesterol in Small LDL,39991,-0.00740641796000258,0.00358642435295708,-0.0144358096917984,-0.00037702622820671,0.0389270254706917
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39991,-0.00212730415243704,0.00358881029392362,-0.00916137232852734,0.00490676402365326,0.553349910587515
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39991,-0.0199190193225798,0.00357420002210697,-0.0269244513659094,-0.0129135872792501,2.54396458832915e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23550.Triglycerides in Small LDL,39991,0.04042221649759,0.00357976898307095,0.0334058692907709,0.047438563704409,1.85711115065695e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39991,-0.00867364628278711,0.00420131369950125,-0.0169082211338096,-0.000439071431764672,0.0389855116279629
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39991,-0.0100547664795188,0.00421339400401855,-0.0183130187273951,-0.00179651423164242,0.0170265378458947
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39991,-0.00742087780361265,0.00416629298495016,-0.015586812054115,0.000745056446889667,0.0749034264067305
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39991,-0.0185582190182061,0.00427431016115029,-0.0269358669340607,-0.0101805711023516,1.42178587173035e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39991,-0.0252892636797811,0.00432334481788118,-0.0337630195228282,-0.016815507836734,5.02692880807697e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39991,0.00405203089062232,0.00402623667289493,-0.00383939298825173,0.0119434547694964,0.314235148252617
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39991,0.0372606224798049,0.00341007066924522,0.0305768839680843,0.0439443609915256,1.0750233526605e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39991,-0.0467784136886164,0.00428303586548764,-0.0551731639849722,-0.0383836633922606,1.1336090274067e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23559.Total Lipids in Large HDL,39991,-0.0464839261932564,0.00421811327667916,-0.0547514282155475,-0.0382164241709652,3.85331731823243e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23560.Phospholipids in Large HDL,39991,-0.0458426092675467,0.00412955909365904,-0.0539365450911184,-0.037748673443975,1.57215910631429e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23561.Cholesterol in Large HDL,39991,-0.0509741995990512,0.00431642790760176,-0.0594343982979506,-0.0425140009001517,4.73335150781228e-32
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39991,-0.05334707905866,0.00432293865807196,-0.0618200388284811,-0.044874119288839,7.87462545526524e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39991,-0.0412647751482011,0.00426591239597933,-0.0496259634443206,-0.0329035868520816,4.50200150229943e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23564.Triglycerides in Large HDL,39991,0.0213457423943357,0.00344930009865627,0.0145851142009695,0.028106370587702,6.2235258100493e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39991,-0.0631151273282005,0.00375256259006465,-0.0704701500047272,-0.0557601046516738,6.06643831569155e-63
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39991,-0.0598583213972912,0.00369366925778101,-0.067097913142542,-0.0526187296520404,1.33500891263318e-58
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39991,-0.0544389886401442,0.00363625305210584,-0.0615660446222717,-0.0473119326580168,2.46742805383235e-50
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39991,-0.0720551507332226,0.00380145877217277,-0.0795060099266812,-0.064604291539764,2.93693498708523e-79
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39991,-0.0737623318726067,0.00379214538932716,-0.0811949368356879,-0.0663297269095255,2.55199542978894e-83
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39991,-0.0624195529086238,0.00382146407610277,-0.0699096224977852,-0.0549294833194624,1.69955322946359e-59
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39991,0.0218303450230012,0.00348654948286527,0.0149967080365852,0.0286639820094171,3.91429896038506e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39991,-0.0530855279417255,0.00343530064386954,-0.0598187172037098,-0.0463523386797412,1.74175516280923e-53
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23573.Total Lipids in Small HDL,39991,-0.0462706937562869,0.00345533659277491,-0.0530431534781257,-0.0394982340344481,1.12434331223547e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23574.Phospholipids in Small HDL,39991,-0.045451519031616,0.00346058155313779,-0.0522342588757661,-0.0386687791874659,3.3382205980215e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23575.Cholesterol in Small HDL,39991,-0.0584719190655295,0.00342609647928465,-0.0651870681649274,-0.0517567699661316,9.72730496471063e-65
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39991,-0.061580049768838,0.00341187154227417,-0.0682673179916954,-0.0548927815459806,4.12946266053506e-72
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39991,-0.0402947305188597,0.00349514395038504,-0.0471452126616144,-0.0334442483761051,1.24554561330459e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23578.Triglycerides in Small HDL,39991,0.037305601830058,0.00374460287794485,0.0299661801892861,0.0446450234708299,2.59714172666062e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39221,0.0346732536513881,0.00349851413969021,0.0278161659375953,0.0415303413651809,4.38041540815513e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39221,0.00909673143138802,0.00350826192583253,0.00222053805675627,0.0159729248060198,0.00952480870142768
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39221,0.0107177633828566,0.00347543842449997,0.00390590407083667,0.0175296226948766,0.00204696618200252
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39221,0.00432289381742769,0.00356601708928438,-0.0026664996775697,0.0113122873124251,0.225436457679668
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39221,-0.017214041669044,0.00343784590096457,-0.0239522196349346,-0.0104758637031534,5.58346269022892e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39797,0.0386455618047955,0.00340610665637434,0.0319695927583018,0.0453215308512892,1.00986781120229e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39797,-0.0156143464363731,0.00380992906178108,-0.023081807397464,-0.00814688547528216,4.18201989897992e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39797,-0.0204227284131576,0.00379410323144066,-0.0278591707467813,-0.0129862860795339,7.4392146976361e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39797,0.00945172166971137,0.00364892903644768,0.00229982075827393,0.0166036225811488,0.00959871911511841
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39797,0.00153119042626991,0.00370048246103252,-0.00572175519735383,0.00878413604989366,0.679039851578535
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39987,0.0600225643429473,0.00367502749342787,0.0528195104558287,0.0672256182300659,1.7385080827533e-59
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39987,0.0148264469985294,0.00356933269171823,0.00783055492276165,0.0218223390742971,3.28621272225128e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39987,0.00532104061747955,0.00372381856626133,-0.00197764377239267,0.0126197250073518,0.153046458098637
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39987,0.0368300559169514,0.00347063469944892,0.0300276119060315,0.0436324999278713,3.20144473067186e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39987,-0.0357345129020194,0.00341996395992567,-0.0424376422634738,-0.0290313835405651,1.78962773794882e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39991,-0.00492472717928289,0.0037537400693503,-0.0122820577152095,0.00243260335664369,0.189554965382173
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39991,-0.0239193713878131,0.00390553320142444,-0.031574216462605,-0.0162645263130212,9.30878636910707e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39991,-0.0275191521933961,0.0039161074031597,-0.0351947227035891,-0.0198435816832031,2.19197258174411e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39991,-0.0127793586490136,0.00383767455896505,-0.0203012007845851,-0.00525751651344215,0.000870486558124183
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39991,0.0198388815642887,0.00388364069665257,0.0122269457988496,0.0274508173297277,3.28741242302189e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39991,-0.0409319067549617,0.00371543926389234,-0.0482141677121907,-0.0336496457977328,3.99908943533026e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39991,-0.0162637282393423,0.00360853833709137,-0.0233364633800414,-0.00919099309864322,6.62090421362277e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39991,0.00409466861326753,0.00351185457838053,-0.0027885663603583,0.0109779035868934,0.243649394121366
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39991,-0.0429357651668794,0.00374255779944304,-0.0502711784537878,-0.035600351879971,2.38340950708171e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39991,0.0239612551433867,0.00364306885205954,0.01682084019335,0.0311016700934234,4.94069345618416e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39991,0.0766836927215815,0.00359425515547539,0.0696389526168498,0.0837284328263133,1.27226259105539e-99
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39991,-0.0530453748670617,0.00381456403964709,-0.06052192038477,-0.0455688293493534,1.04107144251106e-43
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39991,-0.0588208112674452,0.00385181786577809,-0.0663703742843703,-0.0512712482505201,2.7728106155167e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39991,-0.00396395232583667,0.00349840222957251,-0.0108208206957988,0.00289291604412545,0.257199572987557
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39991,0.0397449790916012,0.00378836634392656,0.0323197810575051,0.0471701771256972,1.14539967795137e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39991,0.0538944279708531,0.0034882095907991,0.0470575371728869,0.0607313187688193,1.80945208863914e-53
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39991,-0.067657615715484,0.00363712017892921,-0.0747863712661852,-0.0605288601647827,1.95038195125378e-76
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39991,-0.0733422341040309,0.00358203101550567,-0.080363014894422,-0.0663214533136398,5.29696065196911e-92
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39991,-0.0101071166234659,0.00360683920971796,-0.0171765214745131,-0.00303771177241865,0.00508145144621405
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39991,0.0632235067189413,0.00368169797164627,0.0560073786945146,0.0704396347433679,1.63372951459633e-65
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39991,-0.00719773023674401,0.00351315393201007,-0.0140835119434838,-0.00031194853000427,0.0404983650890995
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39991,-0.0609608987676934,0.00365168579812788,-0.0681182029320241,-0.0538035946033628,4.8123239258202e-62
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39991,-0.0313508601247945,0.00345887892357587,-0.0381302628150032,-0.0245714574345858,1.40077729311918e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39991,-0.0497409829831903,0.00387280559192917,-0.0573316819433715,-0.0421502840230091,1.42651136923375e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39991,0.0629714389866081,0.00356910957559914,0.0559759842184338,0.0699668937547824,5.08098050963934e-69
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39991,-0.0165890980644974,0.0034760356596797,-0.0234021279574696,-0.00977606817152514,1.8362179630391e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39991,-0.0423759404387579,0.00361653095386196,-0.0494643411083274,-0.0352875397691885,1.39570748697779e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39991,0.00847435755699125,0.00360270206122743,0.00141306151698548,0.015535653596997,0.0186735490533759
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39991,-0.0500291927362452,0.00375349408181564,-0.0573860411366038,-0.0426723443358865,2.57556442343921e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39991,0.0560675815507274,0.00349550832854195,0.0492163852267852,0.0629187778746696,1.87106356582638e-57
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39991,0.00119275751381496,0.00355862630824083,-0.00578215005033706,0.00816766507796698,0.737498510252199
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39991,-0.0390989091438787,0.00349484733407294,-0.0459488099186617,-0.0322490083690958,5.99466639691858e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39991,0.00203211284443075,0.00356401658651397,-0.00495335966513663,0.00901758535399814,0.568567011044674
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39991,-0.0484789840840496,0.0035732115032751,-0.0554824786304688,-0.0414754895376304,1.05928829018172e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39991,0.0507186448967204,0.00359143391808857,0.0436794344172668,0.057757855376174,5.14633603427759e-45
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39986,0.000152016011787128,0.00395494750777499,-0.00759968110345185,0.00790371312702611,0.969339798428467
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39986,-0.0229526367720985,0.00363192715120951,-0.0300712139884691,-0.0158340595557278,2.68976492184652e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39986,-0.0516556856387859,0.00344408420519629,-0.0584060906809706,-0.0449052805966011,1.64806484027281e-50
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39986,0.0303049787955161,0.00416434462577451,0.0221428633289981,0.0384670942620342,3.56377410037887e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39986,0.0425381377853638,0.00385118128223441,0.0349898224721844,0.0500864530985433,2.91128872503343e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39991,0.00667479737043864,0.00389753333334632,-0.000964367962920138,0.0143139627037974,0.0868109553345075
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39991,-0.0406593735853368,0.00395784667214968,-0.0484167530627502,-0.0329019941079235,1.10986082639822e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39991,-0.0443485038634251,0.0038189190136206,-0.0518335851301215,-0.0368634225967287,4.71310552531464e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39991,0.00290444598370944,0.00390564849921329,-0.0047506250747486,0.0105595170421675,0.457097453577305
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39991,0.0573490347853381,0.00372495253083858,0.0500481278248945,0.0646499417457817,4.16002226771768e-53
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39991,0.0592056035711463,0.00390226350618918,0.0515571670990155,0.0668540400432771,1.22908676615467e-51
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39991,-0.0652597417154139,0.00381118251925996,-0.0727296594531635,-0.0577898239776644,3.74866623350062e-65
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39991,-0.0578108512397902,0.00364964576633412,-0.064964156941805,-0.0506575455377753,4.35388732389481e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39991,-0.0549035136796533,0.00412136262185746,-0.0629813844184939,-0.0468256429408127,2.82629687892522e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39991,0.063007958362811,0.00370277485020154,0.0557505196564159,0.070265397069206,2.26098660171175e-64
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39991,0.000831662811646857,0.00349196412111566,-0.00601258686573984,0.00767591248903355,0.81175633000124
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39991,-0.0417215729511996,0.00346685101642097,-0.0485166009433847,-0.0349265449590145,3.25049600853603e-33
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39991,-0.0442851153047791,0.00340250092509544,-0.0509540171179661,-0.037616213491592,1.5624484594006e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39991,0.0136408771303475,0.00378936300038841,0.00621372564958616,0.0210680286111087,0.000319439941158814
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39991,0.0705432526947729,0.00378280491571433,0.0631289550599728,0.077957550329573,8.34556443592866e-77
CD300E,CMRF35-like molecule 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51867,-0.0074514664905295,0.00297340501289339,-0.0132793403158006,-0.00162359266525845,0.0122148675597565
CD300E,CMRF35-like molecule 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51867,-0.00708587578040454,0.00290699756814764,-0.0127835910139739,-0.00138816054683517,0.0147944186350055
CD300E,CMRF35-like molecule 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49891,-0.0015481769602444,0.00278040487399636,-0.00699777051327725,0.00390141659278846,0.577657190818496
CD300E,CMRF35-like molecule 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49891,-0.00540066889941752,0.00300351766575147,-0.0112875635242904,0.000486225725455371,0.0721704348552491
CD300E,CMRF35-like molecule 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49891,-0.00808162643936522,0.00298516061973276,-0.0139325412540414,-0.002230711624689,0.00678839642287084
CD300E,CMRF35-like molecule 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49891,-0.00214818920430954,0.00275759232950341,-0.00755307017013622,0.00325669176151715,0.435981502960942
CD300E,CMRF35-like molecule 2,Working and living environment,X24009.Traffic intensity on the nearest road,51867,-0.0963859985123089,0.0563554591022609,-0.20684269835274,0.0140707013281224,0.0872173656836944
CD300E,CMRF35-like molecule 2,Working and living environment,X24010.Inverse distance to the nearest road,51867,0.00162020904176503,0.00260142408439963,-0.00347858216365823,0.0067190002471883,0.53341038773704
CD300E,CMRF35-like molecule 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51867,0.00227570028081448,0.00262592381123932,-0.00287111038921458,0.00742251095084355,0.386153044727573
CD300E,CMRF35-like molecule 2,Working and living environment,X24012.Inverse distance to the nearest major road,51867,-0.00592271085116923,0.00265777382213288,-0.0111319475425497,-0.000713474159788793,0.0258585591276323
CD300E,CMRF35-like molecule 2,Working and living environment,X24013.Total traffic load on major roads,51867,-0.0653311613986291,0.0388779368760291,-0.141531917675646,0.010869594878388,0.0928872861584123
CD300E,CMRF35-like molecule 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51867,-0.084442718073085,0.037757852854815,-0.158448109668522,-0.0104373264776476,0.0253315921628503
CD300E,CMRF35-like molecule 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51867,-0.00862409050977016,0.00298011330301198,-0.0144651125836736,-0.00278306843586668,0.0038080696964508
CD300E,CMRF35-like molecule 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51867,-0.00920775377300084,0.0029791643314284,-0.0150469158626005,-0.00336859168340119,0.00199869671962355
CD300E,CMRF35-like molecule 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51867,-0.00780399837278774,0.00294872535154514,-0.0135835000618162,-0.00202449668375927,0.00813589315526433
CD300E,CMRF35-like molecule 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51817,-0.00255887561498087,0.0028606811186665,-0.00816581060756722,0.00304805937760547,0.37106281190607
CD300E,CMRF35-like molecule 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51867,-0.00516818371258821,0.00260547302861371,-0.0102749108486711,-6.14565765053327e-05,0.0473115930248369
CD300E,CMRF35-like molecule 2,Working and living environment,X24021.Average evening sound level of noise pollution,51867,-0.00515178003155427,0.00260489834982193,-0.0102573807972053,-4.61792659032833e-05,0.0479692026859031
CD300E,CMRF35-like molecule 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51867,-0.00517755430536907,0.00260549726427449,-0.0102843289433471,-7.07796673910625e-05,0.0469137831051779
CD300E,CMRF35-like molecule 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51867,-0.00515922697195374,0.00260519172211688,-0.0102654027473028,-5.30511966046459e-05,0.0476724516516244
CD300E,CMRF35-like molecule 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51867,-0.00516940947054792,0.00260525538222677,-0.0102757100197124,-6.31089213834445e-05,0.0472406519797661
CD300E,CMRF35-like molecule 2,Health and medical history,X2405.Number of children fathered,36364,-0.114577247831493,0.0413955047304135,-0.195712437103104,-0.0334420585598829,0.00565074991349995
CD300E,CMRF35-like molecule 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48673,0.00749645121530116,0.00307697082894417,0.00146558839057059,0.0135273140400317,0.0148449948448798
CD300E,CMRF35-like molecule 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48673,0.00391917961892603,0.00280634585888442,-0.00158125826448743,0.00941961750233948,0.162563859286918
CD300E,CMRF35-like molecule 2,Working and living environment,"X24502.Water percentage, buffer 1000m",48673,-0.00453542617487602,0.00274164404877961,-0.00990904851048406,0.000838196160732029,0.0980848196102945
CD300E,CMRF35-like molecule 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48673,0.0048559828782859,0.00290654326254001,-0.00084084191629253,0.0105528076728643,0.0947921292590352
CD300E,CMRF35-like molecule 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48673,0.0030310053871444,0.0028402089621158,-0.00253580417860256,0.00859781495289136,0.285902345761881
CD300E,CMRF35-like molecule 2,Working and living environment,"X24505.Water percentage, buffer 300m",48673,0.00102255026081482,0.00275376793309775,-0.00437483488805677,0.0064199354096864,0.710396653313614
CD300E,CMRF35-like molecule 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51966,0.00484258743656005,0.00293682247867846,-0.000913584621649737,0.0105987594947698,0.0991750536833804
CD300E,CMRF35-like molecule 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51966,0.00438853924313348,0.00277125837231718,-0.0010431271666082,0.00982020565287515,0.113298121687929
CD300E,CMRF35-like molecule 2,Working and living environment,X24508.Distance (Euclidean) to coast,51966,0.00442361150895668,0.00265330897040393,-0.000776874073035025,0.00962409709094839,0.0954846757503279
CD300E,CMRF35-like molecule 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28697,0.0752552577618012,0.0655920012939854,-0.0533050647744102,0.203815580298013,0.251304606625836
CD300E,CMRF35-like molecule 2,Health and medical history,X2704.Years since last cervical smear test,35714,0.114317371541586,0.0396690049706354,0.0365661217991404,0.192068621284031,0.00396144854201602
CD300E,CMRF35-like molecule 2,Health and medical history,X2714.Age when periods started (menarche),39092,-0.0223541837494689,0.0355271241826853,-0.0919873471475321,0.0472789796485943,0.529218035461788
CD300E,CMRF35-like molecule 2,Health and medical history,X2734.Number of live births,39573,0.00987903051083447,0.0339459781692674,-0.0566550867009297,0.0764131477225986,0.771038245361072
CD300E,CMRF35-like molecule 2,Health and medical history,X2744.Birth weight of first child,35645,-0.222120158012071,0.0392218822470117,-0.298995047216214,-0.145245268807928,1.52080858147997e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X2754.Age at first live birth,33607,-0.0236401296553093,0.00433331646836797,-0.0321334299333105,-0.0151468293773081,5.00482732078406e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X2764.Age at last live birth,33587,-0.0182392542763307,0.0043446929518043,-0.0267548524618672,-0.0097236560907943,2.71614636302463e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X2794.Age started oral contraceptive pill,37272,0.00152782043903799,0.00425698364062272,-0.00681586749658255,0.00987150837465853,0.719677479898119
CD300E,CMRF35-like molecule 2,Health and medical history,X2804.Age when last used oral contraceptive pill,36069,-0.00681483296252642,0.00377645853907584,-0.0142166916991151,0.000587025774062231,0.0711687334568103
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2867.Age started smoking in former smokers,29355,0.00332385443012199,0.00587976149416888,-0.00820047809844903,0.014848186958693,0.57188988657319
CD300E,CMRF35-like molecule 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36595,-0.0536215824650149,0.0471979719857187,-0.146129607557024,0.0388864426269937,0.255936394326879
CD300E,CMRF35-like molecule 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36589,0.00928299762660638,0.0522116704146741,-0.0930518763861549,0.111617871639368,0.858886447515995
CD300E,CMRF35-like molecule 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36612,0.116930051459776,0.0530823169176478,0.0128887103011859,0.220971392618365,0.0276262434563555
CD300E,CMRF35-like molecule 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36582,0.0471066084519604,0.0519020665254184,-0.0546214419378597,0.14883465884178,0.364103805771232
CD300E,CMRF35-like molecule 2,Mental health,X28739.Difficulty with standing for long periods,36625,0.288011696112012,0.0487158517732121,0.192528626636516,0.383494765587508,3.46463051237273e-09
CD300E,CMRF35-like molecule 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36648,0.236896085208455,0.0540471064889877,0.130963756490039,0.342828413926871,1.17913756164076e-05
CD300E,CMRF35-like molecule 2,Mental health,X28741.Difficulty learning a new task,36550,0.0703379025297079,0.0613842968245059,-0.0499753192463236,0.190651124305739,0.251874075393113
CD300E,CMRF35-like molecule 2,Mental health,X28742.Difficulty with joining in community activities,36109,0.126306650458946,0.0584233711103088,0.0117968430827405,0.240816457835151,0.0306436554607656
CD300E,CMRF35-like molecule 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36558,0.10766654858791,0.0504189106225262,0.00884548376775826,0.206487613408061,0.0327441847112295
CD300E,CMRF35-like molecule 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36646,0.0980658154332456,0.0685804765809767,-0.0363519186654688,0.23248354953196,0.152759313237604
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29202,0.0452526817709353,0.0618645657858474,-0.0760018671693255,0.166507230711196,0.464518213966902
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2897.Age stopped smoking,29359,0.028587698734378,0.00705414050415978,0.0147615833462249,0.0424138141225312,5.13474707850748e-05
CD300E,CMRF35-like molecule 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35262,-0.0041192633002096,0.00806093477717388,-0.0199186954634704,0.0116801688630512,0.60935003812535
CD300E,CMRF35-like molecule 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35262,0.0151518375169946,0.00865960691853764,-0.00182099204333914,0.0321246670773284,0.0801945359979658
CD300E,CMRF35-like molecule 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35262,-0.0074950391190385,0.0290763513457201,-0.0644846877566499,0.0494946095185729,0.796588326641197
CD300E,CMRF35-like molecule 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35262,-0.0345935549622928,0.0286431304898107,-0.0907340907223217,0.0215469807977361,0.227170986854027
CD300E,CMRF35-like molecule 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35262,-0.033967667077143,0.0310394376583111,-0.0948049648874327,0.0268696307331467,0.273829445046172
CD300E,CMRF35-like molecule 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35262,-0.0433180728321828,0.0264157576806286,-0.0950929578862149,0.00845681222184927,0.101062428720061
CD300E,CMRF35-like molecule 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35262,-0.0295459614434155,0.0119858248969567,-0.0530381782414507,-0.00605374464538033,0.0137130702291714
CD300E,CMRF35-like molecule 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35262,0.00821305143883762,0.0220383716018795,-0.0349821569008463,0.0514082597785215,0.709400605779982
CD300E,CMRF35-like molecule 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35188,0.101571000062766,0.0538885769068599,-0.00405061067467925,0.207192610800212,0.0594778883679488
CD300E,CMRF35-like molecule 2,Mental health,X29003.Recent feelings of depression,35185,0.0752659752855703,0.0522003588781273,-0.0270467281155592,0.1775786786867,0.149367551438526
CD300E,CMRF35-like molecule 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35195,0.0591533391872963,0.0429556423533674,-0.0250397198253039,0.143346398199896,0.168514834932001
CD300E,CMRF35-like molecule 2,Mental health,X29005.Recent feelings of tiredness or low energy,35201,0.159260915473863,0.0436713957047722,0.0736649798925094,0.244856851055217,0.000266714090797607
CD300E,CMRF35-like molecule 2,Mental health,X29006.Recent poor appetite or overeating,35203,0.190356059706696,0.0572111946923952,0.0782221181096009,0.30249000130379,0.000879859701914984
CD300E,CMRF35-like molecule 2,Mental health,X29007.Recent feelings of inadequacy,35167,0.00586129177415457,0.0559546654487975,-0.103809852505489,0.115532436053798,0.916575468894891
CD300E,CMRF35-like molecule 2,Mental health,X29008.Recent trouble concentrating on things,35200,0.00553801723703637,0.0558783703084863,-0.103983588567597,0.11505962304167,0.921053935461317
CD300E,CMRF35-like molecule 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35191,0.161654164874865,0.0976067683524609,-0.0296551010959581,0.352963430845689,0.097713507399467
CD300E,CMRF35-like molecule 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35126,0.265932347471816,0.10646131379207,0.0572681724393583,0.474596522504275,0.0125064187211687
CD300E,CMRF35-like molecule 2,Mental health,X29038#0.Substances taken for depression_None of options listed,32770,0.00663479319589015,0.016119851167632,-0.0249601150926685,0.0382297014844488,0.68064878687475
CD300E,CMRF35-like molecule 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32770,0.00133967475628825,0.0285997622262948,-0.0547158592072496,0.0573952087198261,0.962640073586686
CD300E,CMRF35-like molecule 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32770,-0.0102817987180351,0.0158181780502478,-0.0412854276965207,0.0207218302604505,0.515709674086357
CD300E,CMRF35-like molecule 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32770,-0.0400319998646911,0.0455737261026269,-0.12935650302584,0.0492925032964576,0.379749908228653
CD300E,CMRF35-like molecule 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32770,-0.000317345848741342,0.0272203506721369,-0.0536692331661297,0.053034541468647,0.990698411070283
CD300E,CMRF35-like molecule 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32770,0.0272705056417724,0.029029690753324,-0.0296276882347426,0.0841686995182873,0.347550627886009
CD300E,CMRF35-like molecule 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32770,0.0294572933539441,0.0330968495993559,-0.0354125318607934,0.0943271185686815,0.373472115751369
CD300E,CMRF35-like molecule 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32770,-0.0296245555199689,0.0409777490395383,-0.109940943637464,0.0506918325975262,0.469734199495336
CD300E,CMRF35-like molecule 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32770,0.0108719357010377,0.0324270056955222,-0.0526849954621857,0.0744288668642611,0.737426209764886
CD300E,CMRF35-like molecule 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32770,0.00849556465368206,0.0163686484769613,-0.0235869863611621,0.0405781156685262,0.603763573572344
CD300E,CMRF35-like molecule 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32770,-0.0101425726228131,0.0238965280099657,-0.0569797675223458,0.0366946222767196,0.671257329442907
CD300E,CMRF35-like molecule 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32770,-0.0111307997772735,0.0378612704470132,-0.0853388898534194,0.0630772902988723,0.768773101537197
CD300E,CMRF35-like molecule 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32770,-0.0520941689868631,0.047375178794175,-0.144949519423446,0.0407611814497199,0.271532264767289
CD300E,CMRF35-like molecule 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32770,-0.0401116796746044,0.0286710555505339,-0.0963069485536508,0.016083589204442,0.16183866188686
CD300E,CMRF35-like molecule 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32770,-0.00511931733911646,0.0485270618931178,-0.100232358649627,0.0899937239713945,0.915986148694786
CD300E,CMRF35-like molecule 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32770,-0.0240346250179303,0.047113596248122,-0.116377273664249,0.0683080236283889,0.60996460717178
CD300E,CMRF35-like molecule 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32770,0.0014302918111196,0.0249276677164949,-0.0474279369132104,0.0502885205354496,0.954245626880987
CD300E,CMRF35-like molecule 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32770,-0.00679151536342117,0.0245331130847994,-0.0548764170096279,0.0412933862827856,0.781916638072019
CD300E,CMRF35-like molecule 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32770,-0.0237315083903853,0.0350028461846679,-0.0923370869123344,0.0448740701315637,0.49779693086376
CD300E,CMRF35-like molecule 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35022,-0.05062125407933,0.0503023007628115,-0.149213763574441,0.0479712554157805,0.314273512559623
CD300E,CMRF35-like molecule 2,Mental health,X29059.Recent inability to stop or control worrying,35027,0.0422056935571748,0.0525708807509235,-0.0608332327146352,0.145244619828985,0.422087742966945
CD300E,CMRF35-like molecule 2,Mental health,X29060.Recent worrying too much about different things,35020,0.00681185937230964,0.0482407208585925,-0.0877399535105318,0.101363672255151,0.887710080520421
CD300E,CMRF35-like molecule 2,Mental health,X29061.Recent trouble relaxing,35027,-0.0728954442437365,0.0507340826078486,-0.17233424615512,0.0265433576676466,0.150798849050961
CD300E,CMRF35-like molecule 2,Mental health,X29062.Recent restlessness,35029,-0.0211758223480336,0.0710209891828791,-0.160376961146477,0.118025316450409,0.765584402168041
CD300E,CMRF35-like molecule 2,Mental health,X29063.Recent easy annoyance or irritability,35011,-0.0508966823556175,0.0512913806479981,-0.151427788425694,0.0496344237144589,0.321070405928433
CD300E,CMRF35-like molecule 2,Mental health,X29064.Recent feelings of foreboding,35002,0.00925687868399607,0.0584294203533456,-0.105264785208561,0.123778542576553,0.874122120180158
CD300E,CMRF35-like molecule 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32770,-0.00551516383477706,0.0163277627230024,-0.0375175787718618,0.0264872511023077,0.735538225945147
CD300E,CMRF35-like molecule 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32770,-0.0233224078869553,0.0268063187388097,-0.0758627926150224,0.0292179768411117,0.384305278639095
CD300E,CMRF35-like molecule 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32770,-0.0129316944362008,0.0349590433531778,-0.0814514194084293,0.0555880305360278,0.711458454725564
CD300E,CMRF35-like molecule 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32770,0.0492223595841217,0.0388824718150287,-0.0269872851733346,0.125432004341578,0.205572421400504
CD300E,CMRF35-like molecule 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32770,-0.000240699710018856,0.0244655791219005,-0.0481932347889438,0.0477118353689061,0.992150519122097
CD300E,CMRF35-like molecule 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32770,0.00274705131216668,0.0265481057168689,-0.0492872358928963,0.0547813385172296,0.917588735196168
CD300E,CMRF35-like molecule 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32770,-0.00852251036152333,0.0264220953988922,-0.060309817343352,0.0432647966203053,0.747041813490694
CD300E,CMRF35-like molecule 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32770,-0.000471176316155992,0.0238927285856975,-0.0473009243441231,0.0463585717118111,0.98426678683635
CD300E,CMRF35-like molecule 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32770,0.0165231994485151,0.0318335606062466,-0.0458705793397283,0.0789169782367585,0.603738988954473
CD300E,CMRF35-like molecule 2,Mental health,X29076.Felt loved as a child,34979,-0.0383507822310889,0.04503203599147,-0.12661357277437,0.0499120083121922,0.394435987277441
CD300E,CMRF35-like molecule 2,Mental health,X29077.Physically abused by family as a child,34981,0.0337909770614541,0.0575529683732812,-0.079012840950177,0.146594795073085,0.557129457692675
CD300E,CMRF35-like molecule 2,Mental health,X29078.Felt hated by family member as a child,34969,0.116910552737033,0.0586438676194021,0.00196857220300493,0.231852533271061,0.0462236747023645
CD300E,CMRF35-like molecule 2,Mental health,X29079.Sexually molested as a child,34888,-0.100825671770252,0.0812737949639682,-0.260122309899629,0.058470966359126,0.214791766809482
CD300E,CMRF35-like molecule 2,Mental health,X29080.Someone to take to doctor when needed as a child,34964,-0.0806094446339303,0.0669613847314572,-0.211853758707586,0.0506348694397259,0.228684881512928
CD300E,CMRF35-like molecule 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34967,0.00695818685026941,0.0801881996806031,-0.150210684523713,0.164127058224251,0.930853353272038
CD300E,CMRF35-like molecule 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34906,-0.049167872620305,0.0635961797860762,-0.173816385001014,0.0754806397604044,0.439464243527092
CD300E,CMRF35-like molecule 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34974,0.0115907002849204,0.070404896256308,-0.126402896377443,0.149584296947284,0.869238857058366
CD300E,CMRF35-like molecule 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34936,0.0703990331029201,0.0985956281546791,-0.122848398080251,0.263646464286091,0.475231222538165
CD300E,CMRF35-like molecule 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34935,-0.0655630097310337,0.0969680920611053,-0.2556204701708,0.124494450708733,0.498972403502446
CD300E,CMRF35-like molecule 2,Mental health,X29086.Experienced a violent or sexual assault,34973,0.0895052875391182,0.0779755590552095,-0.0633268082090925,0.242337383287329,0.251049685440834
CD300E,CMRF35-like molecule 2,Mental health,X29087.Experienced a life-threatening injury or illness,34981,0.242892476054059,0.0540123758794846,0.137028219330269,0.348756732777849,6.96240411256743e-06
CD300E,CMRF35-like molecule 2,Mental health,X29088.Experienced a marital separation or divorce,34982,-0.00219018732199691,0.0486671519320532,-0.0975778051088212,0.0931974304648274,0.964105406627445
CD300E,CMRF35-like molecule 2,Mental health,X29089.Experienced the death of a spouse or partner,34993,-0.0615641630910515,0.0778038409640582,-0.214059691380606,0.0909313651985026,0.428800925882601
CD300E,CMRF35-like molecule 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34979,0.0255923047323712,0.0602401435624072,-0.0924783766499469,0.143662986114689,0.67096296373736
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34988,-0.406938948600942,0.0413483994830952,-0.487981811587808,-0.325896085614075,9.2189658850457e-23
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33869,-0.248381695314625,0.0462108231532137,-0.338954908694924,-0.157808481934326,7.83185365101934e-08
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33883,-0.233341517025383,0.046198658366386,-0.3238908874235,-0.142792146627267,4.47646267245446e-07
CD300E,CMRF35-like molecule 2,Mental health,X29104.Ever used cannabis,34975,-0.17616503311834,0.0543207756685072,-0.282633753428614,-0.0696963128080661,0.001186062396041
CD300E,CMRF35-like molecule 2,Mental health,X29108.Ever thought that life not worth living,34926,0.0756412597966198,0.0495994443662836,-0.021573651161296,0.172856170754536,0.127277081735265
CD300E,CMRF35-like molecule 2,Mental health,X29109.Ever contemplated self-harm,34944,0.062776585581205,0.0645281474960791,-0.0636985835111099,0.18925175467352,0.330646183640344
CD300E,CMRF35-like molecule 2,Mental health,X29111.Ever self-harmed,34963,0.054435626846422,0.101367799444951,-0.144245260065683,0.253116513758527,0.591270753626096
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34969,0.0606472973572914,0.0699833414908812,-0.0765200519648356,0.197814646679419,0.386182017840161
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33458,-0.0250976544472546,0.0333768292842115,-0.0905162398443091,0.0403209309497999,0.452100509547357
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33458,-0.0564943339236395,0.0259365650930974,-0.10733000150611,-0.00565866634116857,0.0294173933753325
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33458,-0.0634696938278955,0.0271370954961401,-0.11665840100033,-0.0102809866554609,0.0193634212322234
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33458,-0.0333256413001074,0.0361808462589567,-0.104240099967663,0.0375888173674478,0.357029107129962
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34961,-0.156806180307243,0.0458578428319562,-0.246687552257877,-0.0669248083566087,0.000629857647024799
CD300E,CMRF35-like molecule 2,Health and medical history,X29153.Pain or discomfort today,34977,0.133603687582354,0.0439885860489993,0.0473860589263152,0.219821316238392,0.00239312678273872
CD300E,CMRF35-like molecule 2,Mental health,X29154.Anxiety or depression today,34977,0.0789508352937875,0.0536308472053769,-0.0261656252287513,0.184067295816326,0.141017835607929
CD300E,CMRF35-like molecule 2,Mental health,X29166.Frequency of confiding in someone close,34737,-0.119460890792723,0.0426130735893268,-0.202982515027804,-0.0359392665576429,0.00506587010454015
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34942,0.0170808533613077,0.00837391178203445,0.000667986268520184,0.0334937204540952,0.0413969115351659
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34942,-0.0140785373380547,0.00832703241103181,-0.030399520863677,0.00224244618756768,0.0909216929613336
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34942,-0.020016309572494,0.0103676965376078,-0.0403369947862054,0.000304375641217311,0.0535528301583784
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34942,0.0162897939299664,0.0123380896113594,-0.007892861708298,0.0404724495682308,0.186767168753145
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34942,-0.0587924778641357,0.0191763841094097,-0.0963781907185788,-0.0212067650096927,0.00217553373664226
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34942,0.00367258019111052,0.00901411701994292,-0.0139950891679776,0.0213402495501986,0.683703447778997
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34941,0.00932851528994045,0.00987052563994364,-0.0100177149643491,0.02867474554423,0.344634560054103
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34941,-0.0193347726682949,0.0139761217264537,-0.0467279712521441,0.00805842591555441,0.166565605681528
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34941,0.0223696493234093,0.0225831967995557,-0.0218934164037198,0.0666327150505384,0.321929939123337
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34941,0.0369058767274578,0.0222126851160501,-0.00663098610000036,0.080442739554916,0.0966458703990404
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34941,-0.0505176209148278,0.0297318829658264,-0.108792111527848,0.00775686969819192,0.0893272814739033
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34941,-0.0152259511895798,0.0147801609431403,-0.0441950666381349,0.0137431642589752,0.302956733757103
CD300E,CMRF35-like molecule 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34756,-0.144121955797771,0.0519064027704478,-0.245858505227848,-0.042385406367693,0.00550289806823339
CD300E,CMRF35-like molecule 2,Mental health,X29172.Freuency of feeling that lacks companionship,34891,0.118230217322175,0.0476050765202787,0.0249242673424292,0.211536167301922,0.0130222640102191
CD300E,CMRF35-like molecule 2,Mental health,X29173.Frequency of feeling left out,34846,0.105557796781711,0.048984953021378,0.00954728885981047,0.201568304703612,0.0311911310096286
CD300E,CMRF35-like molecule 2,Mental health,X29174.Frequency of feeling isolated from others,34879,0.0902597216202848,0.0504774352572229,-0.00867605148387209,0.189195494724442,0.0737840869796652
CD300E,CMRF35-like molecule 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34960,-0.0741632796144358,0.0426361094603759,-0.157730054156773,0.00940349492790105,0.081983783458084
CD300E,CMRF35-like molecule 2,Mental health,X29176.Ability to make it through stressful events,34960,0.0676824802870483,0.0414615129282507,-0.013582085052323,0.14894704562642,0.102620034074393
CD300E,CMRF35-like molecule 2,Mental health,X29177.Quick recovery from stressful events,34960,-0.0786030213874253,0.0421341400158753,-0.161185935818541,0.00397989304369037,0.0621317929026453
CD300E,CMRF35-like molecule 2,Mental health,X29178.Hard to snap back when something bad happens,34960,0.0547249860408652,0.0415740724765049,-0.0267601960130843,0.136210168094815,0.188092210384028
CD300E,CMRF35-like molecule 2,Mental health,X29179.Comes through difficult times with little trouble,34960,-0.0193596870008224,0.0421780951728402,-0.102028753539589,0.0633093795379444,0.64624415522669
CD300E,CMRF35-like molecule 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34960,0.0557221111274293,0.0418768801928273,-0.0263565740505122,0.137800796305371,0.183342230491005
CD300E,CMRF35-like molecule 2,Mental health,X29181.General happiness,34891,0.043499017755883,0.0436098792613154,-0.0419763455962951,0.128974381108061,0.318564195477039
CD300E,CMRF35-like molecule 2,Mental health,X29182.Belief that own life is meaningful,34790,-0.0643251179840939,0.0433510582794769,-0.149293192211869,0.0206429562436807,0.137885824440902
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28893,-0.00662593506358973,0.0593661986071585,-0.12298368433362,0.109731814206441,0.91113611069144
CD300E,CMRF35-like molecule 2,Health and medical history,X2946.Father's age,34166,-0.00771839706849613,0.00631927635148597,-0.0201041787174086,0.00466738458041637,0.221960573925975
CD300E,CMRF35-like molecule 2,Health and medical history,X2966.Age high blood pressure diagnosed,29089,-0.0468554408725178,0.0112216257274328,-0.068849827298286,-0.0248610544467495,3.02221846685072e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51388,0.0476944279125898,0.00271805758978969,0.042367035036602,0.0530218207885775,1.47568083275695e-68
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51388,0.02157985098273,0.00322052794475879,0.0152676162110027,0.0278920857544572,2.11395768343075e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30020.Haemoglobin concentration,51388,-0.0184030229064135,0.00343810934124377,-0.0251417172152512,-0.0116643285975757,8.73645493755315e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30030.Haematocrit percentage,51388,-0.00393235704171631,0.00336624669469328,-0.0105302005633151,0.00266548647988253,0.242747280671398
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30040.Mean corpuscular volume,51388,-0.0325956816327815,0.00272624770122229,-0.0379391271271772,-0.0272522361383858,7.26473863671593e-33
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51387,-0.0436402782944201,0.0027272406374215,-0.0489856699437662,-0.0382948866450739,2.26011057244374e-57
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51387,-0.0308929385683996,0.00266224685569406,-0.03611094240556,-0.0256749347312393,4.64073546886723e-31
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51388,0.0433040090618899,0.00259357684100205,0.0382205984535259,0.0483874196702539,2.80945442281371e-62
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30080.Platelet count,51388,0.0156685789234659,0.00275310207821559,0.0102724988501633,0.0210646589967685,1.27396629435765e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30090.Platelet crit,51388,0.0269459797559548,0.0028181436918149,0.0214224181199976,0.032469541391912,1.25272471028108e-21
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51388,0.0130192169778814,0.00265540464804633,0.00781462386771058,0.0182238100880522,9.49633298771896e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30110.Platelet distribution width,51388,0.00253560985053501,0.00263002048610864,-0.00261923030223792,0.00769045000330794,0.335002908392599
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30120.Lymphocyte count,51351,-0.0119594526775746,0.00278100277602313,-0.0174102181185799,-0.00650868723656921,1.71069509321731e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30130.Monocyte count,51351,0.111960295873506,0.00268576859647612,0.106696189424413,0.1172244023226,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30140.Neutrophill count,51351,0.043216519795664,0.00269273498393258,0.0379387592271561,0.0484942803641719,1.05786465083817e-57
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30150.Eosinophill count,51351,0.0360330397444643,0.00264344779601422,0.0308518820642765,0.0412141974246522,3.58909919206451e-42
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30160.Basophill count,51351,0.133042123065402,0.0281857527993772,0.077798047578623,0.188286198552182,2.36783708029971e-06
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30170.Nucleated red blood cell count,51351,0.1027994340555,0.122558566693148,-0.137415356663069,0.343014224774069,0.401601170718369
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30180.Lymphocyte percentage,51351,-0.0558517336388273,0.00270848349947382,-0.061160361297796,-0.0505431059798587,9.11802852027409e-94
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30190.Monocyte percentage,51351,0.0872048913846818,0.0026830207751524,0.081946170665383,0.0924636121039805,1.98847967117272e-227
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30200.Neutrophill percentage,51351,0.0179606803971015,0.00268548396877834,0.012697131818296,0.0232242289759071,2.30480344993924e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30210.Eosinophill percentage,51351,0.0212649490349531,0.00261509634720983,0.0161393601944218,0.0263905378754844,4.41299537086785e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30220.Basophill percentage,51351,0.00810906222550753,0.00260205752253766,0.00300902948133373,0.0132090949696813,0.00183259877986846
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51350,0.108393374624766,0.122704172254082,-0.132106802993235,0.348893552242768,0.377043283232657
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30240.Reticulocyte percentage,50901,0.0127607900135683,0.00280217039209966,0.00726853604505293,0.0182530439820836,5.28912364000469e-06
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30250.Reticulocyte count,50901,0.0164107335339846,0.0028731470912731,0.0107793652350893,0.0220421018328799,1.12984158612526e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30260.Mean reticulocyte volume,50901,0.00251233368938691,0.00271245467646896,-0.00280407747649225,0.00782874485526606,0.354339176241059
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30270.Mean sphered cell volume,50901,-0.0212969339211645,0.00272242492527126,-0.0266328867746961,-0.0159609810676328,5.35464710752245e-15
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50901,0.0251897021652941,0.00282271439484385,0.0196571819514002,0.0307222223791881,4.77852343346198e-19
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50901,0.0204732216839843,0.00286336937901396,0.014861017701117,0.0260854256668517,8.89512748949902e-13
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50901,0.0234171707284174,0.00291204863077455,0.0177095554120993,0.0291247860447356,9.23648900276978e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30500.Microalbumin in urine,32082,0.0657646487127257,0.00522624260060229,0.0555212132155453,0.0760080842099062,5.5740977935207e-36
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51509,0.0251022091990555,0.00278101121351699,0.0196514272205622,0.0305529911775488,1.88832551314408e-19
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30520.Potassium in urine,51447,-0.00351932336526093,0.00258186102562169,-0.00857977097547944,0.00154112424495758,0.172863512983345
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30530.Sodium in urine,51449,-0.0166755428896078,0.00268623653246811,-0.0219405664932453,-0.0114105192859703,5.45061927564995e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30600.Albumin,48697,-0.0819730999728659,0.00284191282196634,-0.0875432491039199,-0.0764029508418118,5.53287339753471e-180
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30610.Alkaline phosphatase,50985,0.0855638346257055,0.00268714266442855,0.0802970350034256,0.0908306342479855,1.79472700983874e-218
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30620.Alanine aminotransferase,50975,0.0174934236275199,0.00289071448018167,0.0118276232463639,0.023159224008676,1.4530143483523e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30630.Apolipoprotein A,48561,-0.0603240032933408,0.00312882139217965,-0.066456493222013,-0.0541915133646687,3.17501460471482e-82
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30640.Apolipoprotein B,50820,0.00214226808648051,0.00278030737293161,-0.00330713436446544,0.00759167053742647,0.441001308282442
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30650.Aspartate aminotransferase,50895,0.0321011789696117,0.00270964912527778,0.0267902666840673,0.0374120912551562,2.68158986157673e-32
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30660.Direct bilirubin,46769,-0.00616442268660297,0.00297635230908632,-0.0119980732124122,-0.000330772160793784,0.0383575008002892
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30670.Urea,50976,0.038566240521337,0.00284172054120232,0.0329964682605805,0.0441360127820936,8.10267289914977e-42
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30680.Calcium,48693,-0.0144437346696043,0.00281473670541785,-0.0199606186122233,-0.00892685072698532,2.89652885282189e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30690.Cholesterol,50990,-0.0135359965042535,0.00285593467483867,-0.0191336284669373,-0.00793836454156971,2.15222490422101e-06
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30700.Creatinine,50979,0.117205348978585,0.00337886316080349,0.110582777183411,0.12382792077376,5.25038724147309e-258
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30710.C-reactive protein,50905,0.151323816839341,0.00281826102762628,0.145800025225193,0.156847608453488,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30720.Cystatin C,50985,0.258613738308986,0.00276864945015163,0.253187185386689,0.264040291231283,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50975,0.016336633464061,0.00294464066269081,0.010565137765187,0.0221081291629349,2.91784184728475e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30740.Glucose,48658,-0.0189997129915107,0.00285691183646318,-0.0245992601909785,-0.0134001657920429,2.98299718364987e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50750,0.0177610560254788,0.00287014267785002,0.0121355763768928,0.0233865356740648,6.17277480366249e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30760.HDL cholesterol,48676,-0.0680890914872093,0.00330591762642986,-0.0745686900350119,-0.0616094929394068,1.80014963956809e-93
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30770.IGF-1,50864,-0.0321733629688124,0.0028042089475791,-0.0376696125060674,-0.0266771134315574,2.11485856634588e-30
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30780.LDL direct,50931,-0.00318651731145365,0.00282639429098533,-0.0087262501217849,0.0023532154988776,0.259577352790709
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30790.Lipoprotein A,45581,0.0104974580037475,0.00297774108399053,0.00466108547912603,0.0163338305283689,0.000423859393650425
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30810.Phosphate,48631,0.0097630104548872,0.00281292616755077,0.0042496751664877,0.0152763457432867,0.000519858339997917
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30830.SHBG,48448,0.000649989105498207,0.00326697961381103,-0.00575329093757142,0.00705326914856783,0.842297872331076
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30840.Total bilirubin,50883,-0.0143777741372799,0.00277046250762003,-0.0198078806522151,-0.00894766762234461,2.12193714506276e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30850.Testosterone,48810,-0.0138545315992315,0.00463875871779145,-0.0229464986861027,-0.00476256451236025,0.00282289979616459
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30860.Total protein,48677,0.00687667055740571,0.00285795995643158,0.00127506904279982,0.0124782720720116,0.016129058395031
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30870.Triglycerides,50966,0.0406318011212675,0.00283703527083444,0.035071211990432,0.046192390252103,2.35756642021848e-46
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30880.Urate,50954,0.0740703053039628,0.00339855074247542,0.067409145848711,0.0807314647592146,2.05853817192275e-104
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30890.Vitamin D,49885,-0.0107800497279261,0.00296392841105852,-0.0165893494136008,-0.00497075004225139,0.00027627682618327
CD300E,CMRF35-like molecule 2,Physical measures,X3137.Number of measurements made,50008,0.0286433342206183,0.0327702621461898,-0.0355863795859137,0.0928730480271504,0.382090966888497
CD300E,CMRF35-like molecule 2,Physical measures,X3143.Ankle spacing width,39984,0.0141066607899683,0.0048871895811276,0.00452776921095822,0.0236855523689784,0.00390123664189715
CD300E,CMRF35-like molecule 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39983,-0.0110791991986833,0.00375465571160041,-0.0184383243934202,-0.00372007400394654,0.00317418624096108
CD300E,CMRF35-like molecule 2,Physical measures,X3146.Speed of sound through heel,39984,-0.0150059208369635,0.00364580195716148,-0.022151692673,-0.00786014900092703,3.87513865991049e-05
CD300E,CMRF35-like molecule 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39984,-0.0138070485642998,0.00368219984521764,-0.0210241602609263,-0.0065899368676732,0.000177683616192818
CD300E,CMRF35-like molecule 2,Physical measures,X3148.Heel bone mineral density (BMD),39974,-0.0139485063548934,0.00368731928376427,-0.0211756521510713,-0.0067213605587154,0.000155615194991626
CD300E,CMRF35-like molecule 2,Health and medical history,X3526.Mother's age at death,35384,-0.000349979935372431,0.00495815852542819,-0.0100679706452117,0.00936801077446681,0.943727938829251
CD300E,CMRF35-like molecule 2,Health and medical history,X3581.Age at menopause (last menstrual period),30402,-0.030548171026799,0.00676196218233995,-0.0438016169041853,-0.0172947251494127,6.36283702768401e-06
CD300E,CMRF35-like molecule 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30380,0.00728717322223424,0.00610138900265552,-0.00467154922297058,0.0192458956674391,0.232385862967719
CD300E,CMRF35-like molecule 2,Physical measures,X4100.Ankle spacing width (left),32845,0.0119722480110013,0.00627159809568837,-0.000320084256547871,0.0242645802785506,0.0562987040096026
CD300E,CMRF35-like molecule 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32844,-0.0116542906694082,0.00482718933555441,-0.0211155817670948,-0.00219299957172153,0.0157852663126163
CD300E,CMRF35-like molecule 2,Physical measures,X4103.Speed of sound through heel (left),32845,-0.0205064323444268,0.00471221210639055,-0.0297423680729523,-0.0112704966159013,1.36540408707973e-05
CD300E,CMRF35-like molecule 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32845,-0.0180640078633411,0.00475414599521387,-0.0273821340139603,-0.00874588171272196,0.000145867212862552
CD300E,CMRF35-like molecule 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32837,-0.0178147749649579,0.00476657387313698,-0.0271572597563064,-0.00847229017360939,0.000187058790192087
CD300E,CMRF35-like molecule 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32845,-0.0180671026290467,0.00475419688054912,-0.027385328514923,-0.00874887674317047,0.000145509012274882
CD300E,CMRF35-like molecule 2,Physical measures,X4119.Ankle spacing width (right),32838,0.0145055058909272,0.00613459088633111,0.00248170775371823,0.0265293040281362,0.0180734705608863
CD300E,CMRF35-like molecule 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32838,-0.011029542279034,0.00484529856921578,-0.020526327474697,-0.0015327570833711,0.02284916313126
CD300E,CMRF35-like molecule 2,Physical measures,X4122.Speed of sound through heel (right),32838,-0.0229198100754986,0.00471635880488654,-0.0321638733330762,-0.013675746817921,1.19590720965165e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32838,-0.0192425467146669,0.00476276692864985,-0.0285775698948206,-0.00990752353451315,5.38500047090569e-05
CD300E,CMRF35-like molecule 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32828,-0.0194577468537207,0.00478111092706337,-0.0288287242707649,-0.0100867694366765,4.74749820815583e-05
CD300E,CMRF35-like molecule 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32838,-0.019242604530711,0.00476278462366885,-0.0285776623931019,-0.00990754666832003,5.38506628020912e-05
CD300E,CMRF35-like molecule 2,Physical measures,X4194.Pulse rate,33138,0.0228971555419481,0.00456024495768149,0.0139590754248924,0.0318352356590038,5.23494865581255e-07
CD300E,CMRF35-like molecule 2,Physical measures,X4195.Pulse wave reflection index,33138,-0.00722737395376614,0.00446837116734341,-0.0159853814417592,0.00153063353422694,0.105814836387776
CD300E,CMRF35-like molecule 2,Physical measures,X4196.Pulse wave peak to peak time,33133,-0.00935227241980777,0.00480515955557304,-0.0187703851487309,6.5840309115394e-05,0.0516491171634074
CD300E,CMRF35-like molecule 2,Physical measures,X4198.Position of the pulse wave peak,33138,0.0100414566012524,0.00459690732173693,0.00103151825064799,0.0190513949518568,0.0289582553222616
CD300E,CMRF35-like molecule 2,Physical measures,X4199.Position of pulse wave notch,33138,0.0153538760569839,0.00451351945847861,0.00650737791836579,0.024200374195602,0.000672379209713161
CD300E,CMRF35-like molecule 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33138,0.0124271980886395,0.00471257663855989,0.00319054787706215,0.0216638483002169,0.00837752438530699
CD300E,CMRF35-like molecule 2,Physical measures,X4269.Number of triplets attempted (left),33000,0.269406454143453,0.158235256399072,-0.0407346483987278,0.579547556685635,0.088682795886255
CD300E,CMRF35-like molecule 2,Physical measures,X4270.Volume level set by participant (left),32913,0.0643034266217954,0.0452473411756571,-0.0243813620824926,0.152988215326083,0.155306534709303
CD300E,CMRF35-like molecule 2,Physical measures,X4276.Number of triplets attempted (right),33010,0.123275724891484,0.151971581722318,-0.174588575284259,0.421140025067226,0.417285640388059
CD300E,CMRF35-like molecule 2,Physical measures,X4277.Volume level set by participant (right),32909,0.10070649511517,0.0453038312033314,0.0119109859566407,0.1895020042737,0.0262462574643084
CD300E,CMRF35-like molecule 2,Cognitive function,X4288.Time to answer,33173,-0.00835220842648047,0.00515250480529533,-0.0184511178448593,0.00174670099189837,0.105051570038415
CD300E,CMRF35-like molecule 2,Cognitive function,X4290.Duration screen displayed,33173,0.00800759501816834,0.00459320989729637,-0.000995096380532537,0.0170102864168692,0.0813046392818371
CD300E,CMRF35-like molecule 2,Physical measures,X46.Hand grip strength (left),52212,-0.0519442883174123,0.00369763088307591,-0.0591916448482411,-0.0446969317865836,1.11931474295997e-44
CD300E,CMRF35-like molecule 2,Physical measures,X47.Hand grip strength (right),52191,-0.0544263544840229,0.00366529363946897,-0.0616103300173821,-0.0472423789506637,1.08444898780311e-49
CD300E,CMRF35-like molecule 2,Physical measures,X48.Waist circumference,52271,0.0574536972302869,0.00581017950273123,0.0460657454049337,0.0688416490556401,5.08961231203488e-23
CD300E,CMRF35-like molecule 2,Health and medical history,X4803.Tinnitus,32955,0.105433488045754,0.0557602921716539,-0.00385668461068797,0.214723660702195,0.058678195592796
CD300E,CMRF35-like molecule 2,Working and living environment,X4825.Noisy workplace,33095,0.141331669585576,0.0613449552495304,0.0210955572964964,0.261567781874656,0.0212512464016346
CD300E,CMRF35-like molecule 2,Working and living environment,X4836.Loud music exposure frequency,33033,0.167682614605724,0.0665412428628675,0.0372617785945038,0.298103450616944,0.0117529833121578
CD300E,CMRF35-like molecule 2,Physical measures,X49.Hip circumference,52268,0.0173292180964028,0.00459100278036891,0.00833085264687977,0.0263275835459259,0.000160587770623946
CD300E,CMRF35-like molecule 2,Physical measures,X50.Standing height,52244,0.0131552225758846,0.00364741409019928,0.00600629095909399,0.0203041541926751,0.000310616870158284
CD300E,CMRF35-like molecule 2,Health and medical history,X5057.Number of older siblings,32298,-0.0192478471881412,0.047835501281399,-0.113005429699683,0.0745097353234009,0.687417684863775
CD300E,CMRF35-like molecule 2,Physical measures,X51.Seated height,52104,0.00587888765485751,0.00338066157273623,-0.000747209027705509,0.0125049843374205,0.0820499677238997
CD300E,CMRF35-like molecule 2,Eye measures,X5181.Ever had eye surgery,30141,0.302381709740078,0.118568674529112,0.0699871076630192,0.534776311817136,0.0107875996846911
CD300E,CMRF35-like molecule 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30126,0.00254598895781522,0.00559535125277232,-0.00842089949761853,0.013512877413249,0.649111613548785
CD300E,CMRF35-like molecule 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30124,0.0013737239896152,0.00554324072926429,-0.00949102783974281,0.0122384758189732,0.804282071647547
CD300E,CMRF35-like molecule 2,Eye measures,X5190.Duration at which refractometer first shown (right),30069,5.88138470104864e-05,0.00545397566415586,-0.010630978454735,0.010748606148756,0.991396393316266
CD300E,CMRF35-like molecule 2,Eye measures,X5193.Duration at which refractometer first shown (left),30067,0.00158635434586667,0.00546571466021297,-0.00912644638815076,0.0122991550798841,0.771644386795787
CD300E,CMRF35-like molecule 2,Eye measures,"X5199.logMAR, initial (right)",30102,-0.000691854080355884,0.0565220202252235,-0.111475013721794,0.110091305561082,0.990234181499131
CD300E,CMRF35-like molecule 2,Eye measures,X5200.Final number of letters displayed (right),30102,-0.0966729867055984,0.441321450845079,-0.961663030361953,0.768317056950757,0.826615575278018
CD300E,CMRF35-like molecule 2,Eye measures,"X5201.logMAR, final (right)",30049,0.00788631027176901,0.00531993695513709,-0.00254076616029968,0.0183133867038377,0.138283022273151
CD300E,CMRF35-like molecule 2,Eye measures,X5202.Number of rounds to result (right),30102,-0.0783267238715257,0.0545326653166229,-0.185210747892107,0.0285573001490552,0.150959599479119
CD300E,CMRF35-like molecule 2,Eye measures,"X5206.logMAR, initial (left)",30098,0.00625036924544553,0.0561529784836321,-0.103809468582473,0.116310207073364,0.911374372838534
CD300E,CMRF35-like molecule 2,Eye measures,X5207.Final number of letters displayed (left),30098,0.114606509532297,0.390892403135393,-0.651542600613073,0.880755619677668,0.769385185609071
CD300E,CMRF35-like molecule 2,Eye measures,"X5208.logMAR, final (left)",30050,0.00730099745616925,0.00531126754755048,-0.00310908693702969,0.0177110818493682,0.169297708891532
CD300E,CMRF35-like molecule 2,Eye measures,X5209.Number of rounds to result (left),30094,-0.0372350413126117,0.0543694835362124,-0.143799229043588,0.0693291464183647,0.493462919622609
CD300E,CMRF35-like molecule 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29853,-0.020259682707195,0.00550029726048849,-0.0310402653377525,-0.00947910007663759,0.000232189857561053
CD300E,CMRF35-like molecule 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29853,-0.0201678040177181,0.00540267061478739,-0.0307570384227013,-0.00957856961273478,0.000191017047006467
CD300E,CMRF35-like molecule 2,Eye measures,X5256.Corneal hysteresis (right),29853,0.00308654632516157,0.00555750741148153,-0.00780616820134224,0.0139792608516654,0.578653301787507
CD300E,CMRF35-like molecule 2,Eye measures,X5257.Corneal resistance factor (right),29853,-0.00868711290323127,0.00545484774700563,-0.0193786144873623,0.00200438868089978,0.111314116771035
CD300E,CMRF35-like molecule 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29832,-0.0179511182839559,0.0055524124615797,-0.0288338467086521,-0.00706838985925968,0.0012315015389441
CD300E,CMRF35-like molecule 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29832,-0.0157593063993117,0.00541719826647336,-0.0263770150015995,-0.00514159779702394,0.00363779355748033
CD300E,CMRF35-like molecule 2,Eye measures,X5264.Corneal hysteresis (left),29832,0.00611268148784071,0.00554220677855896,-0.00475004379813485,0.0169754067738163,0.270100803491989
CD300E,CMRF35-like molecule 2,Eye measures,X5265.Corneal resistance factor (left),29832,-0.00458861296598561,0.00542668076512855,-0.0152249072656376,0.00604768133366635,0.397829164552586
CD300E,CMRF35-like molecule 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29948,0.387533204672383,0.2235125459246,-0.0505513853398332,0.825617794684599,0.082998528662918
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52172,0.0490094876364344,0.0158551720919885,0.0179333503361369,0.0800856249367319,0.00199628434191384
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52172,0.0183995883008239,0.0177208486186629,-0.0163332749917555,0.0531324515934032,0.299138457056461
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52172,0.0451955823404541,0.0417672453413394,-0.0366682185285711,0.127059383209479,0.279225330987803
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52172,-0.0120640318301432,0.00731527656280597,-0.0264019738932429,0.0022739102329565,0.0991267851591329
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52172,-0.00244733162571402,0.00655830634203916,-0.0153016120561108,0.0104069488046827,0.709028296836868
CD300E,CMRF35-like molecule 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37947,-0.0120922159446344,0.00758953221224096,-0.0269676990806267,0.00278326719135787,0.111120829586463
CD300E,CMRF35-like molecule 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37947,0.0181362805505076,0.0268858356314213,-0.0345599572870782,0.0708325183880935,0.499962375129397
CD300E,CMRF35-like molecule 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37947,-0.00725509057730453,0.0129181518632972,-0.032574668229367,0.0180644870747579,0.574383984163409
CD300E,CMRF35-like molecule 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37947,0.0129464761526478,0.0081915187710013,-0.00310890063851479,0.0290018529438103,0.114020983371215
CD300E,CMRF35-like molecule 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52256,0.0440530880063865,0.0148404558599533,0.014965794520878,0.073140381491895,0.00299559720720319
CD300E,CMRF35-like molecule 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52256,0.0440530880063865,0.0148404558599533,0.014965794520878,0.073140381491895,0.00299559720720319
CD300E,CMRF35-like molecule 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52256,-0.0203854503092858,0.0108775600458815,-0.0417054679992136,0.000934567380641963,0.0609292465785557
CD300E,CMRF35-like molecule 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52256,-0.0198921314029381,0.0168987684403812,-0.0530137175460852,0.013229454740209,0.239151502889252
CD300E,CMRF35-like molecule 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52256,-0.0112013033164401,0.0424019335750726,-0.0943090931235824,0.0719064864907022,0.791651125039455
CD300E,CMRF35-like molecule 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52256,0.0354979283207325,0.0293419839159181,-0.0220123601544669,0.0930082167959319,0.226365767505709
CD300E,CMRF35-like molecule 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52256,0.116927719247911,0.0448036247485633,0.0291126147407274,0.204742823755095,0.00906473185008519
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52171,0.018785761844635,0.0083410317917956,0.00243733953271565,0.0351341841565544,0.0243165828078855
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52171,0.0381721397180376,0.0144115513125957,0.00992549914534998,0.0664187802907251,0.00808424722064079
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52171,0.0142168386392957,0.00699288649210533,0.000510781114769291,0.0279228961638222,0.0420574930671671
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52171,0.0708668894990521,0.0132020798441353,0.044990813004547,0.0967429659935573,8.0303434868841e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52171,0.0317499058284624,0.0114332966607897,0.00934064437331459,0.0541591672836102,0.00549045467631265
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52171,0.0682439222772844,0.00930868256984525,0.0499989044403877,0.0864889401141811,2.34186615708571e-13
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30133,0.0663716129406793,0.0267551876541587,0.0139314451385282,0.11881178074283,0.0131384666302453
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30133,0.032451311979062,0.0232418777191981,-0.0131027683505662,0.0780053923086903,0.162690699124263
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30133,0.153237932174194,0.0290893689815595,0.0962227689703373,0.21025309537805,1.42643181328636e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30133,-0.0213552943045089,0.023992880622912,-0.0683813403254164,0.0256707517163986,0.373463528909723
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52122,0.0714358203810755,0.0232202969364455,0.0259240383856425,0.116947602376509,0.00209689522696823
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52122,0.0364410627286986,0.0335489687101806,-0.0293149159432554,0.102197041400653,0.277397501754833
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52122,0.31266664571851,0.0696266132102357,0.176198483826448,0.449134807610572,7.1296998876836e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52122,0.00992893720322695,0.06031454071298,-0.108287562594214,0.128145437000668,0.869244820066845
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52122,-0.00213063551257451,0.0214424147548767,-0.0441577684321329,0.0398964974069839,0.920848806722189
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52122,0.00143796571316149,0.027184416559489,-0.0518434907434369,0.0547194221697598,0.957814593876161
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52122,0.0293836517910766,0.0112364710850579,0.00736016846436298,0.0514071351177901,0.00892683174103263
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33635,0.160293815310942,0.0213880373630566,0.118373262079351,0.202214368542533,7.22969956248473e-14
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33635,0.10953273960452,0.0242725483465507,0.0619585448452808,0.15710693436376,6.47802333501078e-06
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33635,0.154504291897366,0.0310341698745662,0.0936773189432158,0.215331264851515,6.51658332221288e-07
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33635,0.0184628598796252,0.00921628183753887,0.000398947478049055,0.0365267722812014,0.0451740199590562
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35799,0.016871796927763,0.0104667085622596,-0.00364295185426574,0.0373865457097918,0.10699954265366
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35799,-0.0521817958983038,0.00845117166588449,-0.0687460923634374,-0.0356174994331702,6.85260152591467e-10
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35799,0.0106427157254047,0.00837981059875309,-0.0057817130481514,0.0270671444989607,0.204094237983685
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35800,0.0337924375599864,0.0204984103850351,-0.00638444679468239,0.0739693219146552,0.0992683376463729
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35800,0.0900452679994574,0.0133047421472137,0.0639679733909184,0.116122562607996,1.36769482930689e-11
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35800,0.0223416486637817,0.0167444913448284,-0.010477554372082,0.0551608516996454,0.182141297223534
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52171,-0.0453284783565414,0.0193824169827548,-0.0833180156427409,-0.00733894107034191,0.0193610395204139
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52171,0.00595782177180053,0.0126855998440507,-0.0189059539225388,0.0308215974661399,0.638607034112397
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52171,0.022863000234714,0.0380066305939185,-0.0516299957293663,0.0973559961987943,0.547476581460445
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52171,-0.00183039226714692,0.0143435668775288,-0.0299437833471034,0.0262829988128095,0.898457988231682
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52171,-0.0436602385728114,0.0157324680400878,-0.0744958759313834,-0.0128246012142393,0.00552094177133591
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52171,0.10163456486036,0.0173073107721047,0.0677122357470347,0.135556893973685,4.34456883921808e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52171,0.0116548530480283,0.0056063167239787,0.000666472269030003,0.0226432338270265,0.0376374725018551
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28103,0.108234149182738,0.0191997580455408,0.0706026234134785,0.145865674951998,1.83985654931873e-08
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28103,0.0979051434669643,0.0243824150295574,0.0501156100090319,0.145694676924897,6.0370824069184e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28103,-0.0973401933882561,0.0178654981874035,-0.132356569835567,-0.0623238169409452,5.36746418987303e-08
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28103,-0.00215301836723221,0.0149068515576418,-0.0313704474202102,0.0270644106857457,0.885166633522377
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52308,0.0200851758401068,0.00600329100649293,0.00831872546738066,0.0318516262128329,0.00082183019947477
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52308,0.0187072607385988,0.0176716439449017,-0.0159291613934084,0.0533436828706061,0.289789468091034
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52308,-0.000884480130759404,0.00606509410447666,-0.0127720645755337,0.0110031043140148,0.884055655037163
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52308,0.00750728096536655,0.00589460058576376,-0.00404613618273042,0.0190606981134635,0.202820571071817
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52308,0.0402584488760588,0.00852256173713485,0.0235542278712745,0.0569626698808431,2.32639781664039e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52308,0.0140330577958397,0.00877578699536497,-0.00316748471507568,0.031233600306755,0.109817165491515
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52308,0.0196228633327256,0.0064977490805361,0.0068872751348748,0.0323584515305763,0.0025304245725337
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52308,0.176049782160281,0.0183640472751639,0.14005624950096,0.212043314819602,9.81395137684542e-22
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43093,-0.0326036562058858,0.00636359274475173,-0.0450762979855991,-0.0201310144261724,3.0286827456805e-07
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43093,0.00133440075455881,0.00668765327375633,-0.0117733996620036,0.0144422011711212,0.841848732745778
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43093,0.0323592897561435,0.00799696927174838,0.0166852299835167,0.0480333495287704,5.22047068638248e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43094,-0.00823435924355719,0.0109877778976881,-0.0297704039230258,0.0133016854359114,0.453618818727717
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43094,0.00473091811729731,0.00706039903866459,-0.00910746399848529,0.0185693002330799,0.502825136742281
CD300E,CMRF35-like molecule 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52064,-0.00838848592970847,0.00663979956722054,-0.0214024930814607,0.00462552122204378,0.206468720185825
CD300E,CMRF35-like molecule 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52064,-0.0161402487306455,0.00520538335585877,-0.0263428001081287,-0.00593769735316231,0.00193264486505952
CD300E,CMRF35-like molecule 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52064,0.0103605189814289,0.00621247200934709,-0.00181592615689135,0.0225369641197492,0.0953870551962755
CD300E,CMRF35-like molecule 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52064,-0.0433162094723947,0.00966630585442006,-0.062262168947058,-0.0243702499977313,7.45321137290075e-06
CD300E,CMRF35-like molecule 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52080,-0.0390101615174263,0.00571200308550709,-0.0502056875650202,-0.0278146354698324,8.69346552427673e-12
CD300E,CMRF35-like molecule 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52080,-0.0429241913399497,0.00783442432359744,-0.0582796630142007,-0.0275687196656987,4.315812512521e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52171,-0.0451001691238876,0.00604613210305736,-0.05695058804588,-0.0332497502018951,8.94493937723691e-14
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52171,-0.0452675152751744,0.00743418477055386,-0.0598385174254599,-0.0306965131248888,1.15005155794288e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52171,0.0190446073588083,0.0111388302085346,-0.00278749984991946,0.0408767145675361,0.0873231964746948
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52171,-0.0424838553684692,0.0129895684712245,-0.0679434095720693,-0.0170243011648691,0.00107442770954206
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52171,0.0191984897184165,0.0128132849776796,-0.00591554883783556,0.0443125282746686,0.13405948451066
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52171,-0.0928019265956155,0.0182841803530503,-0.128638920087594,-0.0569649331036368,3.88858996159315e-07
CD300E,CMRF35-like molecule 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39984,-0.0138058127571516,0.00368221852953368,-0.0210229610750376,-0.00658866443926559,0.000177934834032648
CD300E,CMRF35-like molecule 2,Physical activities,X864.Number of days or week walked 10+ minutes,51787,-0.0875094463491146,0.0254060454834848,-0.137305295496745,-0.0377135972014844,0.000573096575302636
CD300E,CMRF35-like molecule 2,Physical activities,X874.Duration of walks,48136,-0.00370217794464419,0.0026883828029773,-0.00897140823847969,0.00156705234919132,0.168493342010901
CD300E,CMRF35-like molecule 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51054,-0.161186905826683,0.0247593589332873,-0.209715249335926,-0.112658562317439,7.63884913512703e-11
CD300E,CMRF35-like molecule 2,Physical activities,X894.Duration of moderate activity,44890,-0.0422041777748828,0.0300204037436395,-0.101044169112416,0.0166358135626506,0.159783513335193
CD300E,CMRF35-like molecule 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30334,-0.0233039941755395,0.00532519396837113,-0.0337413743535469,-0.0128666139975321,1.22675702335723e-05
CD300E,CMRF35-like molecule 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51056,-0.231014377037442,0.0254162965507553,-0.280830318276922,-0.181198435797961,1.06356778306937e-19
CD300E,CMRF35-like molecule 2,Physical activities,X914.Duration of vigorous activity,39923,-0.00361103400046281,0.00338538030297036,-0.0102463793942847,0.00302431139335909,0.286143529259049
